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Purpose: To update the 2008 International Classiﬁcation of
Corneal Dystrophies (IC3D) incorporating new clinical, histopath-
ologic, and genetic information.
Methods: The IC3D reviewed worldwide peer-reviewed articles
for new information on corneal dystrophies published between 2008
and 2014. Using this information, corneal dystrophy templates and
anatomic classiﬁcation were updated. New clinical, histopathologic,
and confocal photographs were added.
Results: On the basis of revisiting the cellular origin of corneal
dystrophy, a modiﬁed anatomic classiﬁcation is proposed consist-
ing of (1) epithelial and subepithelial dystrophies, (2) epithelial–
stromal TGFBI dystrophies, (3) stromal dystrophies, and (4)
endothelial dystrophies. Most of the dystrophy templates are
updated. The entity “Epithelial recurrent erosion dystrophies”
actually includes a number of potentially distinct epithelial
dystrophies (Franceschetti corneal dystrophy, Dystrophia Smolan-
diensis, and Dystrophia Helsinglandica) but must be differentiated
from dystrophies such as TGFBI-induced dystrophies, which are
also often associated with recurrent epithelial erosions. The
chromosome locus of Thiel-Behnke corneal dystrophy is only
located on 5q31. The entity previously designated as a variant of
Thiel-Behnke corneal dystrophy on chromosome 10q24 may
represent a novel corneal dystrophy. Congenital hereditary endo-
thelial dystrophy (CHED, formerly CHED2) is most likely only an
autosomal recessive disorder. The so-called autosomal dominant
inherited CHED (formerly CHED1) is insufﬁciently distinct to
continue to be considered a unique corneal dystrophy. On review of
almost all of the published cases, the description appeared most
similar to a type of posterior polymorphous corneal dystrophy
linked to the same chromosome 20 locus (PPCD1). Confocal
microscopy also has emerged as a helpful tool to reveal in vivo
features of several corneal dystrophies that previously required
histopathologic examination to deﬁnitively diagnose.
Conclusions: This revision of the IC3D classiﬁcation includes an
updated anatomic classiﬁcation of corneal dystrophies more accu-
rately classifying TGFBI dystrophies that affect multiple layers
rather than are conﬁned to one corneal layer. Typical histopathologic
and confocal images have been added to the corneal dystrophy
templates.
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INTRODUCTION
Dedication
We dedicate this work to the memory of Gordon
K. Klintworth, MD, PhD, a brilliant ophthalmic pathologist,
and a highly esteemed member of the International Committee
for Classiﬁcation of Corneal Dystrophies (IC3D), whose legacy
of excellence in corneal research and teaching is legendary.
International Committee for the Classification
of Corneal Dystrophies
In 2008, the ﬁrst IC3D report sought to develop a “new
classiﬁcation system for corneal dystrophies” through inte-
gration of the then current information on phenotype,
pathology, and especially genetics.1 This project was initially
undertaken to correct the shortcomings of the century-old
phenotypic method of corneal dystrophy classiﬁcation.
Cornea Dystrophy: History and Definition
In 1890, the term corneal dystrophy was introduced into
the literature by Groenouw2 and then by Biber.3 Groenouw
reported 2 patients with “noduli corneae,” although he did not
distinguish between the one patient having granular corneal
dystrophy (GCD) and the other having macular corneal
dystrophy (MCD). Subsequently, Biber described a patient
with lattice corneal dystrophy (LCD). Thereafter, Fuchs,4
Uhthoff,5 and Yoshida6 continued to use the term “corneal
dystrophy.”
The general term corneal dystrophy describes an
inherited disorder that affects, singly or in combination, cells,
tissues, and/or organs.1 In ophthalmology, corneal dystro-
phies have typically referred to a group of inherited disorders
that are usually bilateral, symmetric, slowly progressive, and
not related to environmental or systemic factors.7 There are
exceptions to each part of the dystrophy deﬁnition. Epithelial
basement membrane dystrophy (EBMD) and central cloudy
dystrophy of François (CCDF) are likely degenerative rather
than hereditary conditions in the majority of patients. Corneal
dystrophies can also be clinically unilateral, for example,
posterior polymorphous corneal dystrophy (PPCD). Systemic
changes are occasionally seen as in Schnyder corneal
dystrophy (SCD), where hypercholesterolemia is common.
Another challenge is that it is unclear where to draw the
dividing line between hereditary bilateral essentially stationary
corneal diseases such as cornea plana (from mutations in
keratocan) and the hereditary bilateral diseases called corneal
dystrophies. This is underscored by the entity, posterior
amorphous corneal dystrophy (PACD) (from deletion of
keratocan together with 3 other genes), which is typically
minimally progressive and can be associated with iris abnor-
malities. Consequently, many would agree that the term
corneal dystrophy may have more historic than practical
meaning. However, we have chosen to follow custom, and in
this second edition of IC3D, we have continued to address only
entities that have been traditionally included in corneal
dystrophies.
Keratoconus—Is It a Corneal Dystrophy?
Do the corneal ectatic diseases, keratoconus and pellucid
marginal degeneration, meet the criteria for inclusion in corneal
dystrophies? This is a complex and controversial discussion.
The choice to include keratoconus in a corneal dystrophy
classiﬁcation could be supported by the emerging suggestion of
a genetic basis. There is a family history in 10% of cases,
increased prevalence in ﬁrst-degree relatives of affected
individuals, and markedly increased prevalence in trisomy
21. Keratoconus is likely genetically heterogeneous and may
have incomplete penetrance and variable expressivity.8–13
However, most cases of keratoconus are sporadic, and
in contrast to established corneal dystrophies, potential
causative associations such as eye rubbing and atopy are
noted. There is still insufﬁcient evidence demonstrating a clear
genetic basis in the majority of patients with keratoconus. For
this reason, the IC3D continues to support exclusion of
corneal ectasias from the corneal dystrophy classiﬁcation. As
interest in molecular etiology of keratoconus continues, we
anticipate future new insights into the true genetic basis of
this highly prevalent corneal disease.
Shortcomings of the Historic Corneal
Dystrophy Classification
There were numerous ﬂaws in the traditional and most
widely used corneal dystrophy classiﬁcation system.14,15 Some
of the dystrophies were named before the advent of the slit
lamp, whereas most were described before the development of
genetic mapping. Introduction of genotyping revolutionized
our knowledge base of corneal dystrophies. Genotyping
revealed both genotypic heterogeneity, that is, a single dystro-
phy such as Meesmann corneal dystrophy is associated with
different genes (KRT3 and KRT12) and with phenotypic
heterogeneity, the TGFBI gene is associated with multiple
distinct allelic dystrophy phenotypes, Reis–Bücklers corneal
dystrophy (RBCD), Thiel-Behnke corneal dystrophy (TBCD),
granular corneal dystrophy type 1 (GCD type 1), granular
corneal dystrophy type 2 (GCD type 2), and classic lattice
corneal dystrophy (LCD).1 The IC3D classiﬁcation system
attempts to address these critically important shortcomings.
Dystrophy Versus Degeneration and
Other Questions
As noted previously, a number of entities formerly
considered as corneal dystrophies are more likely degener-
ations rather than inherited diseases. For example, the
majority of epithelial basement membrane dystrophy
(EBMD) cases have no hereditary basis. Central cloudy
dystrophy of François (CCDF), although hereditary in a few
families, is phenotypically identical to posterior crocodile
shagreen. The only distinction is that CCDF is associated with
a family history. There are only a few publications describing
an entire family with CCDF.16–18 Hence, in descriptions
of CCDF patients without a detailed family history, it is
impossible to exclude the diagnostic possibility of posterior
crocodile shagreen degeneration.19
Fuchs endothelial corneal dystrophy (FECD) is a very
common corneal dystrophy and has a familial basis.20,21 Stage
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1 FECD consists of only cornea guttata without corneal
decompensation. Not all patients with stage 1 FECD progress.
Are nonprogressive corneal guttae evidence of a corneal
degeneration rather than FECD? The answer is not known
but has important clinical implications. Often, the patient with
cornea guttata is informed of having a diagnosis of FECD. If
the individual consults the Internet or other sources, their
research will inevitably suggest that FECD is a disease that
often progresses to corneal edema, visual loss, and surgical
intervention. Thus, a premature diagnosis of FECD in the
absence of a family history, genetic evidence, or corneal edema
can have important adverse psychological impact on the patient
who anticipates future visual loss and need for corneal
transplantation surgery.
Other dystrophies were described decades ago
with minimal or unclear clinical information and no genetic
information. In particular, such dystrophies as Grayson-
Wilbrandt might be variants of other well-known dystrophies
or might not even exist.
Misleading dystrophy names have also contributed to
misdiagnosis. Among individuals with the disease formerly
named Schnyder crystalline corneal dystrophy (SCCD), 50%
actually have visible crystalline deposits.22 Correct diagnosis
of those affected patients in the absence of crystals often
confounded even seasoned clinicians who depended on this
ﬂawed assumption coupled with erroneous literature, both
supporting the notion that crystals were integral to the
diagnosis.23,24 Indeed, the compounded errors of SCD were
the major impetus to create the IC3D nomenclature revision
group in 2005. Because the 2008 IC3D publication observed
“once established in textbooks, it is exceedingly difﬁcult to
purge incorrect information about rare diseases. Many myths
are perpetuated because very few ophthalmologists have seen
a substantial number of the unusual corneal dystrophies.”
Even experienced corneal subspecialists often were unable to
correctly diagnose those with acrystalline SCD24 and patients
went undiagnosed for decades.
Formation of the IC3D in 2005 Leading to
Publication in 2008
Initially, the ﬁrst requirement for membership in the
IC3D group was extensive ﬁrsthand knowledge and experi-
ence in examining patients with one or more distinct corneal
dystrophies. In this way, each dystrophy could be discussed
and analyzed by those who had seen the disease rather than
solely being informed by published descriptions, which might
be erroneous. The group was to critically assess the published
literature to purge errors. The members were also necessarily
international to assess geographically distinctive founder
effects on globally distinct population. Although SCD was
extremely common in central Massachusetts in the United
States and the west coast of Finland, GCD type 2 was
extremely common in Korea. In some cases, the IC3D was
fortunate to include the individual who originally described
the dystrophy, as in Lisch epithelial corneal dystrophy
(LECD) and X-linked endothelial corneal dystrophy. The
second requirement for membership in the IC3D was
representation from geneticists and ophthalmic pathologists.
The 2008 IC3D publication contained the traditional
anatomic classiﬁcation that organized dystrophies according
to the corneal layer that was chieﬂy affected.14,15 Templates
for each dystrophy were created in a standard format to
summarize clinical, pathological, and genetic information as
well as representative clinical photographs.
An evidence-based category system was suggested by
Professor Gordon K. Klintworth, MD, PhD, to indicate the
level of evidence supporting existence of a given corneal
dystrophy depending on how substantive was the knowledge
of its clinical, pathological, and genetic basis. He postulated
that existence of a new corneal dystrophy must begin with
identiﬁcation of a clinical phenotype and should progress to
characterization of the causative gene mutation.
An example of a monogenic category 1 dystrophy is
SCD, which is caused by mutations in 1 gene, UBIAD1.
Another category 1 dystrophy PACD is caused by deletion of
multiple genes, keratocan (KERA), lumican (LUM), decorin
(DCN), and epiphycan (EPYC). The genetic basis of other
dystrophies, such as some types of FECD, may prove to be
complex and involve multiple genes.
These categories were speciﬁed as follows:
“Category 1: A well-deﬁned corneal dystrophy in which
the gene has been mapped and identiﬁed and the speciﬁc
mutations are known.
Category 2: A well-deﬁned corneal dystrophy that has been
mapped to one or more speciﬁc chromosomal loci, but the
gene(s) remains to be identiﬁed.
Category 3: A well-deﬁned corneal dystrophy in which the
disorder has not yet been mapped to a chromosomal locus.
Category 4: This category is reserved for a suspected, new,
or previously documented corneal dystrophy, although the
evidence for it, being a distinct entity is not yet convincing.”1
We postulated that with increased knowledge about
a dystrophy, its category should progress over time from 4 to
3 to 2 to 1. Suspected dystrophies that remain category 4
because no further information ever becomes available may
be eventually removed from the nomenclature. The group did
not further specify speciﬁc criteria for removal of a category 4
dystrophy.
Corneal Dystrophy Purgatory and the Category 4
Dilemma—When Can a Category 4 Dystrophy
Be Eliminated?
In some cases, additional information might show that
a category 4 dystrophy is not an independent entity. One such
example is central discoid corneal dystrophy (CDCD).25,26
This category 4 dystrophy was phenotypically indistinguish-
able from acrystalline SCD. When the causative gene for
SCD was found to be UBIAD1,27,28 genetic testing of CDCD
similarly demonstrated mutations in UBIAD1 indicating that
CDCD was not a unique dystrophy. CDCD was consequently
removed before publishing the ﬁrst IC3D classiﬁcation, in
which it was reclassiﬁed as SCD variant.26
Should elimination also be considered for a category 4
corneal dystrophy in which no further information to prove or
disprove its unique existence is forthcoming? In such a case,
there is no evidence to substantiate or to disprove the
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existence of the dystrophy. We consider this the equivalent of
corneal dystrophy “purgatory.”
A case in point is Grayson-Wilbrandt, a category 4
dystrophy, which was described in 1 publication in 1966
supported only by artist’s renditions of phenotype, without
clinical photographs or genotyping.29 Over the ensuing 4
decades, while no subsequent articles have disputed the
original publication, there also have been no articles sub-
stantiating these ﬁndings. Most members of the IC3D agreed
that this entity should be eliminated from the classiﬁcation. It
is now being consigned to a category of “Removed Dystro-
phies” (Table 1) so that in the event a future publication
seems to substantiate the existence of this entity, the reference
publication remains readily retrievable for future use.
Has the IC3D Been Accepted?
The IC3D 2008 classiﬁcation system successfully
integrated the then most currently accurate clinical, patho-
logical, and genetic information regarding corneal dystro-
phies. The nomenclature has been incorporated by the
American Academy of Ophthalmology’s widely used Basic
and Clinical Science Course Series,30 which instructs oph-
thalmology residents in the United States and Europe and has
been referenced by the National Eye Institute. Nonetheless,
the recommendations of the IC3D have been incorporated
only in a minority of new publications. They had been cited
114 times by July 2014, according to Thomson Reuters’ Web
of Science, as opposed to about 800 articles published on
corneal dystrophies since 2009. It is unclear whether the
editors and reviewers reject the new classiﬁcation, think it
unimportant, or remain creatures of habit. For example,
despite the nomenclature revision to GCD type 2, the name
Avellino is still used, although its prevalence is seemingly
decreasing. Recognizing that change is an evolutionary
process, such incremental progress is encouraging.
Revising the IC3D Nomenclature
The nomenclature revision was conﬁgured to be user-
friendly and easily accessible to physicians and patients on
www.corneasociety.org and open access through the journal
Cornea. One stated requirement of the original nomenclature
revision was that it be easily “upgradeable.” Six years after
the original publication, sufﬁcient new information had
become available to begin our ﬁrst revision of the IC3D.
Changes in the 2015 IC3D
Anatomic Classiﬁcation Change
The traditionally accepted “anatomic level” corneal
dystrophy classiﬁcation has limitations,14,15 as dystrophies
were solely assigned to the single layer most affected. Yet
RBCD and TBCD affect not only the subepithelial area with
destruction of the Bowman layer but also the anterior stroma
and later the deeper stroma. Although categorized anatomi-
cally as “Bowman layer dystrophies,” TGFBI dystrophies
affect multiple layers. Other corneal dystrophies also affect
more than 1 layer. MCD affects both the stroma and
endothelium, and SCD involves epithelium, stroma, and
endothelium. As we understand the primary cell(s) of origin,
it may be less important to categorize dystrophies as being
conﬁned to 1 speciﬁc layer. In addition, histopathology,
although affording improved resolution at the cellular level, is
also subject to individual case and disease stage variation.
In this revision of the original IC3D from 2008, we
include a proposed alteration of the century-old anatomic
level classiﬁcation to more accurately reﬂect involvement of
the cellular layers. We now exclude the Bowman acellular
layer and Descemet acellular membrane. Dystrophies are now
divided into epithelial and subepithelial dystrophies,
epithelial-stromal TGFBI dystrophies, stromal dystrophies,
and endothelial dystrophies (Table 1).
What We Have Removed and Added
The IC3D elected to remove the extensive table of gene
loci and genes with speciﬁc mutations because this informa-
tion is rapidly changing and can be more easily obtained on
the Internet. For similar reasons, a table of mutations is not
included in this revision although templates still include the
gene locus and gene.
The classic articles on corneal dystrophy classiﬁcation by
Waring, Rodrigues, and Laibson14,15 included clinical drawings
and histopathologic photographs. As clinicopathological
TABLE 1. The IC3D Classification (C = Category)
Epithelial and subepithelial dystrophies
1. Epithelial basement membrane dystrophy (EBMD) majority
degenerative, rarely C1
2. Epithelial recurrent erosion dystrophies (EREDs)—Franceschetti corneal
dystrophy (FRCD) C3, Dystrophia Smolandiensis (DS) C3, and
Dystrophia Helsinglandica (DH) C3
3. Subepithelial mucinous corneal dystrophy (SMCD) C4
4. Meesmann corneal dystrophy (MECD) C1
5. Lisch epithelial corneal dystrophy (LECD) C2
6. Gelatinous drop-like corneal dystrophy (GDLD) C1
Epithelial–stromal TGFBI dystrophies
1. Reis–Bücklers corneal dystrophy (RBCD) C1
2. Thiel-Behnke corneal dystrophy (TBCD) C1
3. Lattice corneal dystrophy, type 1 (LCD1) C1—variants (III, IIIA, I/IIIA,
IV) of lattice corneal dystrophy C1
4. Granular corneal dystrophy, type 1 (GCD1) C1
5. Granular corneal dystrophy, type 2 (GCD2) C1
Stromal dystrophies
1. Macular corneal dystrophy (MCD) C1
2. Schnyder corneal dystrophy (SCD) C1
3. Congenital stromal corneal dystrophy (CSCD) C1
4. Fleck corneal dystrophy (FCD) C1
5. Posterior amorphous corneal dystrophy (PACD) C1
6. Central cloudy dystrophy of François (CCDF) C4
7. Pre-Descemet corneal dystrophy (PDCD) C1 or C4
Endothelial dystrophies
1. Fuchs endothelial corneal dystrophy (FECD) C1, C2, or C3
2. Posterior polymorphous corneal dystrophy (PPCD) C1 or C2
3. Congenital hereditary endothelial dystrophy (CHED) C1
4. X-linked endothelial corneal dystrophy (XECD) C2
Removed dystrophies
Grayson-Wilbrandt corneal dystrophy (GWCD) C4
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correlation remains a hallmark of corneal dystrophy diagnosis,
we have included representative histopathology and electron
microscopy, as well as confocal microscopy in some cases.
Findings on the emerging technique of anterior
segment optical coherence tomography (OCT) were added
to the templates when available. We expect that this method
will reﬁne clinical diagnostics of several dystrophies,
especially the differential diagnosis between TBCD and
RBCD by providing images that are highly similar to
histopathologic sections.
Reclassiﬁed Corneal Dystrophies
Congenital Hereditary Endothelial Dystrophy
One challenge of the dystrophy nomenclature has been
the tendency to emphasize a new or rare observation instead
of waiting for a complete analysis of a new disorder. In the
2008 IC3D publication, we observed that “inconsistencies in
the literature have confounded our understanding of precise
ﬁndings in speciﬁc corneal dystrophies.” Since then, we have
learned more about congenital hereditary endothelial dystro-
phy (CHED). In 2008, we followed convention by including
2 types of CHED: an autosomal dominant (AD) form with
less severe ﬁndings was called CHED1 and an autosomal
recessive (AR) form with more severe ﬁndings was termed
CHED2. Further review of the clinical and pathological
descriptions of the 5 families previously reported with
CHED1 suggests that many and possibly all of these families
have PPCD.31–33 Consequently, AD CHED (CHED1) has
been eliminated. Autosomal recessive CHED, previously
called CHED2, is now called simply CHED.34
Is the 10q23-24 Dystrophy Distinct or a Variant of TGFBI
Thiel-Behnke Corneal Dystrophy?
In 1997, Yee et al35 reported a dystrophy affecting the
Bowman layer that mapped to 10q23-24, which they called
Thiel-Behnke corneal dystrophy (TBCD). The article sug-
gested that the affected individual had corneal ﬁndings
consistent with TBCD. The histological features of this patient
were subsequently reported by Lohse et al36; however, there
were different pedigrees in both articles. Clariﬁcation of the
10q Thiel-Behnke phenotype37 presented other challenges.
Nakamura et al38 described a mixture of honeycomb-like,
geographic-like, and map-like opacity patterns of the presented
patients in their legends, but these were not compatible with the
accompanying black and white photographs that did not
demonstrate a typical honeycomb-like pattern. Consequently,
given the genetic heterogeneity, phenotypic heterogeneity and
absence of corroborating histopathology of the 10q23-24
dystrophy, we believe that there is insufﬁcient evidence to
consider this a variant of TBCD. Is it a distinct dystrophy?
Because this is not presently known, we hope ongoing
investigations will resolve this uncertainty before the next
IC3D revision. The 10q23-24 dystrophy is thus still listed as
a footnote to TBCD and not promoted to a template.
Expanded Templates
In 2008, the epithelial recurrent erosion dystrophy
template included both Franceschetti39 hereditary recurrent
erosion and Dystrophia Smolandiensis (DS),40 which shared
recurrent erosions as their major and often only clinical
ﬁnding. At that time, it was unclear whether these 2 entities
were variants of the same condition or whether these were
distinct dystrophies. Lisch et al41 observed that the affected
members of the original Franceschetti’s family showed
recurrent erosions in the ﬁrst decades, as well as diffuse
subepithelial opacities in the advanced age. The authors
termed this entity “Franceschetti corneal dystrophy”
(FRCD). In 2009, another entity, Dystrophia Helsinglandica
(DH)42 was published and has been added to the epithelial
recurrent erosion dystrophy’s template. Future information,
especially future identiﬁcation of the underlying gene(s) will
reveal whether these 3 entities are unique entities or allelic
variants of one and the same disorder.
Diagnosis of a Corneal Dystrophy in the
Pediatric Patient
Diagnosing corneal dystrophies in the pediatric patient
remains a challenge. Most publications contain photographs
of the most classic advanced cases found in adults. Few
photographs document the earliest and most subtle corneal
changes as would occur in children, and there is no atlas of
corneal dystrophy ﬁndings in children. This markedly
increases the difﬁculty of making the correct diagnosis in
the pediatric patient.43,44
Sporadic Corneal Dystrophy?
It is important to be cautious before making the
diagnosis of a sporadic corneal dystrophy. It is mandatory
to obtain the family history and examine the parents and other
family members. For example, paraproteinemic immunotac-
toid keratopathy can mimic SCD, lattice corneal dystrophy, or
GCD type 1.45 Mucolipidosis IV can cause a cornea verti-
cillata pattern similar to GCD type 1.
A PLEA TO REVIEWERS AND EDITORS
More Stringent Criteria for Publishing the
New Unique Corneal Dystrophy
An 8-year-old boy is examined and noted to have an
unusual conﬁguration of bilateral corneal ﬂecks. Is this
a unique new corneal dystrophy? There is a systematic
approach to determining whether this is a corneal dystro-
phy that has already been described or rather a unique new
entity.
Do other family members have similar corneal
ﬁndings? If so, the inheritance is likely AD or X-linked.
Even if there is no family history, family members should
still be examined to detect subtle or previously unappre-
ciated corneal changes. If no abnormalities are evident, the
inheritance could be AR or there could be incomplete
penetrance or poor expressivity. Although a classical
phenotype–genotype correlation facilitates diagnosis, this
does not always occur. Histopathology and genotyping can
add more information.
If geneticists discover a new mutation, a novel type of
corneal dystrophy can be constructed phenotypically. We
advise peer-reviewed journals to strengthen the criteria
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required for publication of a “new” corneal dystrophy.
A minimum of approximately 10 affected members in 3
generations is reasonably convincing to demonstrate a dis-
tinct dominant phenotype clinically and scientiﬁcally. Such
a rigorous systematic approach also avoids creation of more
category 4 dystrophies that may be destined only for
eventual elimination. Corneal photographs with a dilated
pupil also facilitate diagnosis. When the gene or gene locus
has been identiﬁed, it is preferable to include photographs
with genetic conﬁrmation. We have attempted to do both
when possible for this article.
As an example, a 27-year-old woman demonstrated
rare bilateral lattice lines atypical for classic LCD. Genotyp-
ing demonstrated the classical Arg124Cys TGFBI LCD1
mutation conﬁrming LCD. This was not a unique corneal
dystrophy but rather an additional example of phenotypic
variation resulting from variable penetrance or expressivity
of the gene.
Regarding mutations of TGFBI, a phenotype typical
enough to be clinically recognizable is generally limited to
TBCD, RBCD, GCD1, GCD2, and classic LCD. When any
of these classic mutations is documented, corresponding
terminology should be used without exception, despite any
possible individual variation in phenotype. Other TGFBI
mutations often produce variant, overlapping, or mixed
phenotypes, often with amyloid, and these dystrophies can
be called variant LCD by IC3D conventions. Also, it is ill
appreciated that both Congo red and Masson trichrome
often co-label some deposits in GCD1 and LCD, suggest-
ing a mixed phenotype or GCD2. Also in these cases, the
terminology corresponding to the identiﬁed mutation
should simply be used.
There are frequent submissions to journals of such
“new” dystrophies based on a small change in phenotype.
More than a century away from the original description of
corneal dystrophies, the ﬁeld has progressed from phenotype
to genotype. In the United States, support of the National Eye
Institute has made genotyping more accessible through eye-
GENE.46 We implore authors and reviewers alike to require
genotyping and phenotypic information before proposing the
discovery of any new genetic disease.
EPITHELIAL AND SUBEPITHELIAL DYSTROPHIES
Epithelial Basement Membrane
Dystrophy (EBMD)
Mendelian inheritance in man (MIM) #121820.
Former Alternative Names and Eponyms
Map-dot-ﬁngerprint dystrophy.
Cogan microcystic epithelial dystrophy.
Anterior basement membrane dystrophy.
Inheritance
Isolated familial cases have been reported. However,
because the majority of cases have no documented
inheritance, they are considered to be degenerative or
secondary to trauma.
Genetic Locus
5q31.
Gene
Transforming growth factor beta–induced—TGFBI in 2
families.
Onset
Commonly present in adult life. Rarely described in
children.
Signs
Poor adhesion of basal epithelial cells to abnormal basal
laminar material is thought to predispose to recurrent erosions.
Maps
Irregular islands of thickened, gray, hazy epithelium
with scalloped, circumscribed borders, particularly affecting
the central or paracentral cornea. Isolated or combined with
other signs (Fig. 1A).
Dots (Cogan)
Irregular round, oval, or comma-shaped, nonstaining,
putty-gray intraepithelial opacities, clustered like an archipelago
in the central cornea (Fig. 1B). Typically combined with other
signs, especially with maps.
Fingerprint Lines
Parallel, curvilinear lines, usually paracentral, best
visualized with retroillumination (Fig. 1C). Isolated or com-
bined with other signs, especially maps.
Bleb Pattern (Bron)
Subepithelial pattern like pebbled glass, best seen by
retroillumination (Fig. 1D). Isolated or combined with other
signs.
Symptoms
EBMD can be asymptomatic, associated with painful
erosive episodes and/or may cause decreased vision by
inducing mild irregular astigmatism (monocular diplopia,
“ghost” images).
Course
Location and degree of pathology can ﬂuctuate with
time.
Light Microscopy
Maps
Sheets of intraepithelial, multilamellar, basal laminar
material (Fig. 1F).
Fingerprint Lines
Rib-like intraepithelial extensions of basal laminar
material (Fig. 1E).
Dots
Intraepithelial pseudocysts containing cytoplasmic debris.
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Bleb Pattern
Irregular, subepithelial accumulation of ﬁbrillogranular
material.
In contrast to some other superﬁcial dystrophies, the
Bowman layer is normal.
Transmission Electron Microscopy
Maps
Thick, multilamellar sheets (2–6 nm thick) of
epithelial basement membrane that extend into the
epithelium.
FIGURE 1. Epithelial basement mem-
brane dystrophy. A, Map-like changes.
B, Intraepithelial dot opacities (Cogan
cysts) underlying map-like figures. C,
Fingerprint lines, best visualized with
retroillumination. D, Multiple crow-
ded blebs (Bron), only visible in ret-
roillumination. E and F, Light
microscopy shows excessive base-
ment membrane material (arrow-
heads) intervening between
distorted epithelium and the intact
Bowman layer) to form redundant
sheets corresponding to maps (E)
and fingerprint lines (F) (E, Masson
trichrome; F, PAS, bar = 200 mm.) G,
In vivo confocal microscopy demon-
strates abnormal hyperreflective in-
traepithelial basement membrane
material within suprabasal and basal
epithelial cell layers (400 · 400 mm).
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Fingerprint Lines
Fine ﬁbrillar (17 nm diameter) and granular (8 nm)
substance in addition to undulating waves of the basement
membrane.
Dots
Intraepithelial pseudocysts contain degenerating cells
with pyknotic nuclei and cytoplasmic debris.
Blebs
Discrete noncystic mounds of abnormal granular mate-
rial deposited between the epithelium and Bowman layer that
indents the overlying basal epithelial cells. May mimic cysts
clinically, but no cysts present on histology.
Confocal Microscopy
Maps
Highly reﬂective tissue in various conﬁgurations
corresponds to abnormal basement membrane extending
into the intermediate and basal epithelial cell layers.
Adjacent basal epithelial cells appear distorted. No abnor-
malities in superﬁcial epithelial cells or stroma.
Fingerprint Lines
Linear hyperreﬂective structures corresponding to abnor-
mal basement membrane projecting into the corneal epithelium
(Fig. 1G).
Dots
Hyperreﬂective structures with sharp border within the
intermediate cell layers.
Blebs
Circular or oval hyporeﬂective or hyperreﬂective areas
at the level of the basal epithelium and Bowman layer.
Category
Most cases are sporadic and may be degenerative.
Category 1 in rare cases.
Note: Only 1 publication identiﬁes 2 families with EBMD
with TGFBI mutations.
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Epithelial Recurrent Erosion
Dystrophies (EREDs)
MIM #122400.
Variants
Franceschetti corneal dystrophy (FRCD).
Dystrophia Smolandiensis (DS).
Dystrophia Helsinglandica (DH).
Inheritance
Autosomal dominant.
Genetic Locus
Unknown.
Gene
Unknown.
Onset
Early childhood.
Signs
Recurrent epithelial corneal erosions presenting in the
ﬁrst decades of life lasting 1 to 7 days. During pain-free
intervals, no biomicroscopically evident changes are present
(Fig. 2A). By mid-life, diffuse, central, subepithelial opacity,
subepithelial ﬁbrosis (Fig. 2B), or protruding keloid-like
formations develop.
Symptoms
Severe epithelial erosive attacks commence in child-
hood and recur throughout life. The attacks often start at
night. Visual impairment from central corneal opaciﬁcation
consequent to erosions occurs in approximately 50% of cases.
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By age 30 to 40 years, corneal erosions become less severe
and less frequent.
Course
With advancing age to 30 to 40 years, slow reduction in
frequency of painful erosive episodes. Slow progression of
central opacities impairs visual acuity.
Light Microscopy
FRCD
Based on superﬁcial perilimbal biopsy, irregular basal
epithelium with enlarged intercellular spaces. Alcian blue–
positive deposits were present both intracellularly and
intercellularly. Partial destruction and absence of the Bowman
layer with intervening avascular connective tissue pannus
between the basal epithelium and Bowman layer (Fig. 2C).
Negative Congo red staining.
DS
Keloid-like structure stains positive with Congo red
indicating secondary amyloidosis.
Transmission Electron Microscopy
FRCD
Irregularity in size and shape of the basal epithelial cells
and enlarged intercellular clefts corresponding to Alcian
blue–positive deposits. Presumably “dystrophic” mitochon-
dria in between basal epithelial cells. Pannus contains
numerous ﬁbroblasts (Fig. 2D).
Immunohistochemistry
FRCD
Segmental reduced expression of the tight junction
proteins claudin and E-cadherin, desmosome components.
Decorin expression seems to be enhanced in the basal
epithelial layer compared with the normal postmortem
cornea.
DS
Abundant ﬁbronectin is present in the central subepi-
thelial stroma, localized in areas of subepithelial ﬁbrosis.
Keratocytes in these areas are immunoreactive for S100
calcium-binding protein A4 (S100A4).
Confocal Microscopy
DS
Abnormal thinning of the corneal epithelium, absence
of the Bowman layer with accumulation of pathological
material at the level of the Bowman layer. Subepithelial
corneal nerves are sparse and tortuous.
Category
3.
Note: The difference in severity of corneal opaciﬁcation in
FRCD, DS, and DH could be explained by the presence of
polymorphism and difference in expressivity of a common
gene. The term “Familial recurrent corneal erosions” is
descriptive and not diagnostic as recurrent erosions frequently
occur in other corneal dystrophies. Future DNA analyses will
reveal more information about FRCD, DS, and DH and assist
with differential diagnosis.
FIGURE 2. Franceschetti corneal
dystrophy. A, In first decades of life,
the cornea appears normal without
any dystrophy-specific signs after
recurrent epithelial erosion. B, With
advancing age, diffuse central haze of
the epithelial/subepithelial layer de-
velops. C, Light microscopy: in
advanced age, the Bowman layer
(arrowhead) is partially destroyed and
pannus (pan) develops between the
basal epithelium and Bowman layer
(PAS, · 200 mm). D, Electron micros-
copy of pannus with numerous fibro-
blasts. From Lisch W.41
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Subepithelial Mucinous Corneal
Dystrophy (SMCD)
MIM #612867.
Former Alternative Names and Eponyms
None.
Inheritance
Autosomal dominant inheritance most likely, but
X-linked inheritance not excluded.
Genetic Locus
Unknown.
Gene
Unknown.
Onset
First decade of life.
Signs
Diffuse bilateral subepithelial opacities and haze, most
dense centrally (Fig. 3A).
Symptoms
Painful episodes of recurrent corneal erosions, which
decrease during adolescence (only 1 publication of a single
family).
Course
Progressive loss of vision in adolescence.
Light Microscopy
Subepithelial band of eosinophilic, periodic acid–Schiff
(PAS)–positive, Alcian blue–positive, hyaluronidase-sensitive
material is present anterior to the Bowman layer (Fig. 3B).
Transmission Electron Microscopy
Subepithelial deposits of ﬁne ﬁbrillar material.
Immunohistochemistry
Subepithelial deposits react for chondroitin-4-sulfate
and dermatan sulfate.
Confocal Microscopy
Not reported.
Category
4.
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Meesmann Corneal Dystrophy (MECD)
MIM #122100.
Former Alternative Names and Eponyms
Juvenile hereditary epithelial dystrophy.
Variant
Stocker–Holt variant.
Inheritance
Autosomal dominant.
Genetic Loci
Locus 12q13 (KRT3)
Locus 17q12 (KRT12) Stocker–Holt variant.
FIGURE 3. Subepithelial mucinous
corneal dystrophy. A, Slit-lamp bio-
microscopy reveals that diffuse sub-
epithelial opacities and haze are
densest centrally. B, Light micros-
copy: a band of increased staining is
present beneath the epithelium. The
Bowman layer is thin (Alcian blue)
(·40). Photograph courtesy of
Robert Feder, MD.
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Genes
Keratin K3 (KRT3).
Keratin K12 (KRT12) Stocker–Holt variant.
Onset
Early childhood.
Signs
Multiple, tiny intraepithelial vesicles extend to the
limbus and are most numerous in the interpalpebral area
with clear surrounding epithelium. Direct illumination
shows varying diffuse gray opacities in different patterns,
which may have a distinct border (Fig. 4A). Areas of the
central or peripheral cornea may be unaffected. Whorled and
wedge-shaped epithelial patterns have been reported. The
gray opacities appear as solitary transparent cysts on indirect
illumination (Figs. 4B, C). Approximately 85% of eyes
show microcysts affecting the entire epithelium, while the
remainder are localized in the upper, lower, central, and/or
peripheral cornea. Coalescence of several cysts may result in
refractile linear opacities with an intervening clear cornea.
The cornea may be slightly thinned and corneal sensation
may be reduced.
Stocker–Holt Variant
The entire cornea demonstrates ﬁne grayish punctate
epithelial opacities that stain with ﬂuorescein and ﬁne linear
opacities that may appear in a whorl pattern.
Symptoms
Patients are typically asymptomatic or may have
mild visual reduction, although some patients complain of
glare and light sensitivity. Foreign body sensation or
tearing may escalate to painful recurrent epithelial ero-
sions. Rarely, blurred vision results from corneal irregu-
larity and scarring.
FIGURE 4. Meesmann corneal dys-
trophy. A, In direct illumination,
diffuse gray, superior opacity with
a distinct border is apparent. B, With
retroillumination, the same eye
demonstrates that the opacity pat-
tern is composed of multiple solitary
transparent microcysts. C, Multiple
solitary transparent microcysts in
retroillumination. D, Light micros-
copy: intraepithelial cysts sometimes
extruding onto the corneal surface,
contain amorphous material probably
comprised of degenerated epithelial
cells. The basement membrane is
thickened (Alcian blue and hematox-
ylin and eosin stain, ·400). E, Electron
microscopy: intracytoplasmic fibrillar
peculiar substance, surrounding tan-
gles of filaments. F, In vivo confocal
microscopy shows hyporeflective
areas corresponding to microcysts in
the basal epithelial layer and round
hyperreflective structures (400 ·
400 mm). Figures 4A, B, and C from
Figures 4A and B: Weiss JS, Møller HU,
Lisch W, et al. The IC3D classification
of the corneal dystrophies. Cornea.
2008;27(suppl 2):S1–S42.
Cornea  Volume 34, Number 2, February 2015 IC3D Classification of Corneal Dystrophies
Copyright  2014 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 127
Stocker–Holt Variant
Patients demonstrate more severe signs and symptoms
with earlier onset compared with classic Meesmann corneal
dystrophy.
Course
Stationary or slowly progressive.
Light Microscopy
The thickened and disorganized epithelium always
demonstrates intraepithelial cysts (Fig. 4D) ﬁlled with PAS-
positive cellular debris, which ﬂuoresces. The cells also
contain of PAS-positive and diastase-sensitive material
(glycogen). A thickened multilaminar basement membrane
projects into the basal epithelium.
Stocker–Holt Variant
Variably thickened epithelium with vacuolated and
degenerating cells. Variably thickened basement membrane
extends into the epithelium. The Bowman layer and stroma
remain normal.
Transmission Electron Microscopy
Intracytoplasmic “peculiar substance” represents a focal
collection of ﬁbrogranular material surrounded by tangles of
cytoplasmic ﬁlaments (Fig. 4E). These cysts are round and
uniform (10–50 mm). Some lesions with reﬂective points in
the cytoplasm probably correspond to cell nuclei.
Stocker–Holt Variant
Not reported.
Confocal Microscopy
Hyporeﬂective areas in the basal epithelium ranging
from 40 to 150 mm in diameter, some with reﬂective spots
inside (Fig. 4F).
Numerous corneal intraepithelial microcysts and hyper-
reﬂective material thought to represent degenerative cells
have been detected closer to the basal layer of the corneal
epithelium in older patients. Compared with the basal
epithelial layer, the superﬁcial layer contains larger micro-
cysts with atrophic changes of the hyperreﬂective material.
Clearly visualized demarcation lines between the microcysts
and normal epithelial cells correspond to the biomicroscopi-
cally visible demarcation between clear and affected areas.
Stocker–Holt Variant
Not reported.
Category
1 including Stocker–Holt variant.
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Lisch Epithelial Corneal Dystrophy (LECD)
MIM #300778.
Former alternative names and eponyms
Band-shaped and whorled microcystic dystrophy of the
corneal epithelium.
Inheritance
X-chromosomal dominant.
Genetic Locus
Xp22.3.
Gene
Unknown.
Onset
Childhood.
Signs
Direct illumination shows localized gray opacities in
different patterns: whorl-like, radial, band-shaped ﬂame/
feathery, and club shaped (Figs. 5A, B). Indirect illumination
demonstrates multiple densely crowded clear cysts (Fig. 5C).
Opacities can be minimal or asymmetric with clear surround-
ing epithelium. Similar appearance in males and females.
Symptoms
Asymptomatic or blurred vision if the pupillary axis is
involved.
FIGURE 5. Lisch epithelial corneal
dystrophy. A and B, Diffuse grayish
epithelial opacities form radial,
feathery or club-shaped patterns.
C, Opacification consists of crow-
ded, transparent microcysts in ret-
roillumination. D, Light microscopy:
pronounced vacuolization of the
epithelial cells, particularly in outer
layers (hematoxylin and eosin stain,
·250). E, Electron microscopy: dis-
closes coalescent intracellular va-
cuolization of the wing cells. Some
of these vacuoles coalesce to form
empty spaces within the cytoplasm
of the epithelial cells, ·4000. F, In
vivo confocal microscopy shows in-
traepithelial hyperreflective dystro-
phic areas containing hyporeflective
round structures, sharply demar-
cated from normal epithelial areas
(400 · 400 mm). Figure 5C from
Figure 5C in Weiss JS, Møller HU,
Lisch W, et al. The IC3D classification
of the corneal dystrophies. Cornea.
2008;27(suppl 2):S1–S42.
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Course
Slow progression of opacities with possible visual
deterioration.
Light Microscopy
Epithelial basal cells are cuboidal with low nuclear to
cytoplasmic ratio. In the suprabasal and parabasal layers,
vacuolated cells (Fig. 5D) progress to the epithelial surface,
where they adopt elongated ﬂat squamous shapes. These
vacuoles are PAS positive, diastase labile, Luxol fast blue and
Sudan black negative, consistent with glycogen. Intercellular
cysts, parakeratosis, orthokeratosis, and hyperkeratosis are
not identiﬁed.
Transmission Electron Microscopy
Basal epithelial cells with intact basement membrane
and hemidesmosomes are unremarkable. In the midlevel and
superﬁcial epithelium, there are cells with myriad vacuoles
and inclusions (Fig. 5E) of 2 forms; vaguely ﬂocculent or
lamellar material with or without a circumscribing membrane,
and more electron-dense whorled or membranous structures.
Confocal Microscopy
There are 4 characteristic features of the abnormal
epithelial cells: highly hyperreﬂective cytoplasm and
hyporeﬂective nuclei (Fig. 5F); uniform involvement of
all epithelial layers within the affected areas; well-
demarcated borders with adjacent normal epithelium;
involvement of the limbal area. No distinct intracellular
deposits are present, although the cytoplasm has granular
hyperreﬂectivity.
Category
2.
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FIGURE 6. Gelatinous drop-like cor-
neal dystrophy. A, Band keratopathy
type. B, Mulberry type. C, Fluorescein
staining shows an extremely hyper-
permeable corneal epithelium, here
without superficial punctate keratop-
athy or erosion. D, Kumquat-like
diffuse stromal opacity. E, Light
microscopy: massive amyloid in
a subepithelial lesion (arrowheads)
extending to the midstromal cornea.
Bar = 400 mm (direct fast scarlet
[DFS], ·10). Figures 6A, B, and
D from Figures 6A, B, and C in Weiss
JS, Møller HU, Lisch W, et al. The
IC3D classification of the corneal
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Gelatinous Drop-like Corneal Dystrophy (GDLD)
MIM #204870.
Former Alternative Names and Eponyms
Subepithelial amyloidosis.
Primary familial amyloidosis (Grayson).
Inheritance
Autosomal recessive.
Genetic Locus
1p32.
Gene
Tumor-associated calcium signal transducer 2 (TACSTD2,
previously M1S1).
Onset
First to second decade.
Signs
Initially, subepithelial lesions may appear similar to band-
shaped keratopathy (Fig. 6A) or there may be groups of small
multiple nodules, that is, mulberry conﬁguration (Fig. 6B).
They stain with ﬂuorescein (Fig. 6C), indicating epithelial
hyperpermeability. Superﬁcial vascularization is frequently
seen. In later life, patients may also develop stromal opaciﬁca-
tion or develop larger nodular, kumquat-like lesions (Fig. 6D)
although it is uncertain whether there is a transition of the 4
different phenotypes from one to the other with time.
Symptoms
Signiﬁcant decrease in vision, photophobia, irritation,
redness, and tearing.
Course
Progression of protruding subepithelial deposits and
stromal opacity. Most patients develop recurrence after
superﬁcial keratectomy, lamellar keratoplasty, or penetrating
keratoplasty, typically within a few years.
Light Microscopy
Subepithelial and stromal amyloid deposits (Fig. 6E).
Transmission Electron Microscopy
Disruption of epithelial tight junctions in the superﬁcial
epithelium. Amyloid evident in the basal epithelial layer.
Immunohistochemistry
Deposits stain with antibodies to lactoferrin.
Confocal Microscopy
Epithelial cells are irregular in shape and often
elongated. There is a mild disorganization of the overall
epithelial architecture. Large accumulations of brightly reﬂec-
tive material are noted within or beneath the epithelium and
within the anterior stroma. No evident abnormalities can be
detected in the posterior cornea.
Category
1.
BIBLIOGRAPHY
 Fujiki K, Nakayasu K, Kanai A. Corneal dystrophies in
Japan. J Hum Genet. 2011;46:431–435.
 Ide T, Nishida K, Maeda N, et al. A spectrum of clinical
manifestations of gelatinous drop-like corneal dystrophy in
Japan. Am J Ophthalmol. 2004;137:1081–1084.
 Kaji Y, Oshika T, Takazawa Y, et al. Co-localization of
advanced glycation end products and D-beta-aspartic acid-
containing proteins in gelatinous drop-like corneal dystro-
phy. Br J Ophthalmol. 2012;96:1127–1131.
 Kinoshita S, Nishida K, Dota A, et al. Epithelial barrier
function and ultrastructure of gelatinous drop-like corneal
dystrophy. Cornea. 2000;19:551–555.
 Kitazawa K, Kawasaki S, Shinomiya K, et al. Establish-
ment of a human corneal epithelial line lacking the
functional TACSTD2 gene as an in vitro model for
gelatinous drop-like dystrophy. Invest Ophthalmol Vis
Sci. 2013;5701–5711.
 Klintworth GK, Valnickova Z, Kielar RA, et al. Familial
subepithelial corneal amyloidosis—a lactoferrin-related
amyloidosis. Invest Ophthalmol Vis Sci. 1997;38:2756–
2763.
 Nakaizumi GA. A rare case of corneal dystrophy. Acta Soc
Ophthalmol Jpn. 1914;18:949–950.
 Nakatsukasa M, Kawasaki S, Yamasaki K, et al. Tumor-
associated calcium signal transducer 2 is required for the
proper subcellular localization of claudin 1 and 7: impli-
cations in the pathogenesis of gelatinous drop-like corneal
dystrophy. Am J Pathol. 2010;177:1344–1355.
 Nakatsukasa M, Kawasaki S, Yamasaki K, et al. Two novel
mutations of TACSTD2 found in three Japanese gelatinous
drop-like corneal dystrophy families with their aberrant
subcellular localization. Mol Vis. 2011;19:965–970.
 Paliwal P, Gupta J, Tandon R, et al. Identiﬁcation and
characterization of a novel TACSTD2 mutation in gelati-
nous drop-like corneal dystrophy. Mol Vis. 2010;16:729–
739.
 Ren Z, Lin PY, Klintworth GK, et al. Allelic and locus
heterogeneity in autosomal recessive gelatinous drop-like
corneal dystrophy. Hum Genet. 2002;110:568–577.
Cornea  Volume 34, Number 2, February 2015 IC3D Classification of Corneal Dystrophies
Copyright  2014 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 131
 Tsujikawa M, Kurahashi H, Tanaka T, et al. Identiﬁcation
of the gene responsible for gelatinous drop-like corneal
dystrophy. Nat Genet. 1999;21:420–423.
 Tsujikawa M. Gelatinous drop-like corneal dystrophy.
Cornea. 2012;31(suppl 1):S37–S40.
 Yoshida S, Kumano Y, Yoshida A, et al. Two brothers
with gelatinous drop-like dystrophy at different stages of
the disease: role of mutational analysis. Ophthalmol.
2002;133:830–832.
EPITHELIAL–STROMAL TGFBI DYSTROPHIES
Reis–Bu¨cklers Corneal Dystrophy
MIM #608470.
Former Alternative Names and Eponyms
Corneal dystrophy of Bowman layer, type I (CDB I).
Geographic corneal dystrophy (Weidle).
Atypical Granular Corneal Dystrophy.
Granular Corneal Dystrophy, type 3.
Anterior limiting membrane dystrophy, type 1.
Superﬁcial Granular Corneal Dystrophy.
Inheritance
Autosomal dominant.
Genetic Locus
5q31.
Gene
Transforming growth factor beta-induced—TGFBI.
Onset
Childhood.
Signs
Conﬂuent early irregular geographic-like opacities with
varying densities develop at the level of the Bowman layer
and superﬁcial stroma, initially discrete (Fig. 7A) and
subsequently extending to the limbus and deeper stroma
(Fig. 7B). Can be confused with TBCD especially in the ﬁrst
2 decades. In this early stage, RBCD shows more irregular
diffuse opacities with clear interruptions, whereas TBCD
exhibits multiple ﬂecks with reticular formation.
Symptoms
Vision is impaired from childhood. Painful recurrent
corneal erosions.
Course
Slowly progressive deterioration of vision. Recurrent
corneal erosions tend to abate with time. Similar but
frequently more aggressive course than TBCD but may not
be able to distinguish in an individual case.
Light Microscopy
The Bowman layer is replaced by a sheet-like layer of
granular Masson trichrome–red deposits (Fig. 7C), which can
extend to the subepithelial stroma and, in advanced cases,
sparse round deposits appear in the middle and posterior stroma.
Transmission Electron Microscopy
Subepithelial electron-dense, rod- or trapezoidal-shaped
bodies identical to those in GCD1 (Fig. 7D) replace the
Bowman layer and extend from the basal epithelial cell level to
anterior stroma and, sparsely, to deeper stroma. Basal epithelial
cells may contain vesicles with similar rods. Electron micros-
copy is necessary for deﬁnitive histopathologic diagnosis to
distinguish from TBCD, which demonstrates curly ﬁbers not
rod-shaped bodies.
Immunohistochemistry
Rod-shaped bodies are immunopositive for transform-
ing growth factor beta–induced protein (keratoepithelin).
FIGURE 7. Reis–Bu¨cklers corneal
dystrophy. A, Confluent irregular,
geographic-like opacities. B, Geo-
graphic opacities extend to the lim-
bus and deeper stroma in a more
advanced case. C, Light microscopy:
Masson trichrome stains keratohyalin
intensely red beneath the epithelium
and between superficial stromal
lamellae. Note characteristic destruc-
tion of the Bowman layer. Deeper red
spots (asterisk) are artifact of lamellar
keratoplasty (Arg124Leu TGFBI
mutation), bar = 200 mm. D, Electron
microscopy: broad band of irregularly
arranged, subepithelial rod-shaped
bodies (·3000). E, In vivo confocal
microscopy shows a granular highly
reflective material without any
shadow within the basal epithelium
(Arg124Leu mutation) (400 · 400
mm).
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Optical Coherence Tomography
A homogenous conﬂuent layer of hyperreﬂective depos-
its often with serrated anterior border is apparent at the level of
the Bowman layer and anterior stroma. It is thickest in the
center (72–132 mm), becomes thinner in midperiphery, and
disappears toward the limbus.
Confocal Microscopy
Distinct deposits are found in the epithelium and
Bowman layer. The deposits in the suprabasal and basal
epithelial cell layer show extremely high reﬂectivity from small
granular or amorphous material without shadows (Fig. 7E).
The Bowman layer is replaced by highly reﬂective irregular
material, even more reﬂective than in TBCD. Fine diffuse
round or spindle-shaped deposits may be noted in the anterior
and sparsely even in the posterior stroma.
Category
1.
BIBLIOGRAPHY
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Thiel–Behnke Corneal Dystrophy (TBCD)
MIM #602082.
Former Alternative Names and Eponyms
Corneal dystrophy of Bowman layer, type II (CDB2).
Honeycomb-shaped corneal dystrophy.
Anterior limiting membrane dystrophy, type II.
Curly ﬁbers corneal dystrophy.
Waardenburg–Jonkers corneal dystrophy.
Inheritance
Autosomal dominant.
Genetic Loci
5q31.
Gene
Transforming growth factor beta–induced—TGFBI.
Onset
Early childhood.
Signs
Initial signs are solitary ﬂecks or irregularly shaped
scattered opacities at the level of the Bowman layer, followed
by symmetrical subepithelial honeycomb opacities (Figs. 8A,
B, Ci) with peripheral cornea typically uninvolved. In older
patients, opacities can progress to deeper stromal layers and
the corneal periphery. It is difﬁcult to distinguish from Reis–
Bücklers corneal dystrophy (RBCD) in early or individual
cases.
Rare alleles that combine Arg555Gln with other TGFBI
mutations lead to variants of TBCD with atypical opacities.
Symptoms
Recurrent corneal erosions may be painful in the ﬁrst
and second decades. Gradual visual impairment develops
later. Erosions are less frequent, and the onset of visual
impairment is later than in RBCD.
Course
Slowly progressive deterioration of vision results from
increasing corneal scarring. Recurrent corneal erosions
diminish with time. Similar but frequently less aggressive
course than RBCD but difﬁcult to distinguish individual
cases.
Light Microscopy
Alternating irregular thickening and thinning of the
epithelial layer to compensate for ridges and furrows of
underlying stroma, with focal absence of the epithelial
basement membrane (Fig. 8D). The Bowman layer is replaced
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by a superﬁcial ﬁbrocellular pannus with a pathognomonic
wavy sawtoothed pattern.
Transmission Electron Microscopy
Presence of curly collagen ﬁbers 9 to 15 nm in
diameter (Fig. 8E), importantly distinguishes TBCD from
RBCD.
Immunohistochemistry
Curly ﬁbers are immunopositive for transforming
growth factor beta–induced protein (keratoepithelin).
Confocal Microscopy
Distinct deposits are found in the epithelium and
Bowman layer. The deposits in the basal epithelial cell layer
show homogeneous reﬂectivity with round edges accompa-
nying dark shadows (Fig. 8F). The Bowman layer is replaced
with reﬂective irregular material that is less reﬂective than in
RBCD.
Optical Coherence Tomography
Prominent hyperreﬂective material at the level of the
Bowman layer extending into the epithelium in a characteristic
FIGURE 8. Lattice Corneal Dystro-
phy, type 1 (LCD). A, Initial signs of
mild honeycomb appearance. B,
Intensive honeycomb opacity pat-
tern in advanced disease
(Arg555Gln mutation). C, In a 42-
year-old with genetically confirmed
TBCD: (i) the cornea displays hon-
eycomb opacity while (ii) confocal
microscopy demonstrates the saw-
tooth pattern of hyperreflective
material in the Bowman layer. D,
Light microscopy: varying thickness
of the epithelium due to a thickened
abnormal subepithelial fibrous layer
(arrowheads) that replaces the
Bowman layer and has a characteris-
tic sawtooth-like surface. Masson
trichrome, bar = 200 mm. E, Trans-
mission electron microscopy: sub-
epithelial curly filaments with
a thickness of 10 nm (·50,000). F, In
vivo confocal microscopy image
shows abnormal hyperreflective
material with homogeneous re-
flectivity, round edges, and dark
shadows within the basal epithelium
(400 · 400 mm).
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sawtooth pattern (Fig. 8Cii), a major feature in distinguishing
TBCD from RBCD.
Category
1.
Note: Linkage to 10q24 has been reported in 1 family. The
initial and later descriptions of the phenotype are incomplete
and variable, and light microscopic, immunohistochemical,
and anterior segment optical coherence tomographic evidence
of subepithelial scarring similar to and consistent with TBCD
has not been published.
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Lattice Corneal Dystrophy, type 1 (Classic)
(LCD1) and Variants
MIM #122200.
Former Alternative Names and Eponyms
LCD, type 1.
Biber-Haab-Dimmer.
Inheritance
Autosomal dominant.
Genetic Locus
5q31.
Gene
Transforming growth factor beta–induced—TGFBI.
Onset
First to second decade.
Signs
The ﬁrst signs are central superﬁcial ﬂeck-like opacities
that usually develop by the end of the ﬁrst decade (Fig. 9A).
In retroillumination, isolated peripheral, few, and subtle
lattice lines in deeper layers are visible initially in the
superﬁcial stroma of the same patient (Fig. 9B). Thin
branching refractile lines and/or subepithelial, whitish, ovoid
dots also develop by the end of the ﬁrst decade. These lines
start centrally and more superﬁcially, spreading centrifugally
and deeply, but leaving the far peripheral stroma, Descemet
membrane and the endothelium uninvolved (Figs. 9C, D).
Diffuse subepithelial ground-glass haze of the central and
paracentral cornea develops concurrently with the lattice lines
in the central and paracentral cornea and subsequently
progresses (Fig. 9C), accompanied by recurrent erosions.
Development of diffuse central haze in the second to third
decade may reduce vision sufﬁciently to necessitate surgical
intervention. The number of lattice lines may differ between
the 2 eyes (unilateral cases are described). Variant LCD, type
IIIA also shows central thicker lattice lines (Fig. 10A),
whereas LCD, type IV is characterized more by deeper
deposits without epithelial erosion (Fig. 10B).
Symptoms
Ocular discomfort, pain, and visual impairment, some-
times start as early as the ﬁrst decade as consequent to
frequent recurrent erosive attacks. Visual impairment within
the fourth decade.
Course
Progressive, often with marked visual decrease by the
fourth decade.
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Light Microscopy
Epithelial atrophy and disruption with degeneration of
basal epithelial cells, focal thinning, or absence of the
Bowman layer, progress with age. Eosinophilic amyloid
material accumulates between the epithelial basement mem-
brane and Bowman layer. Stromal deposition of amyloid
distorts the architecture of corneal lamellae. Amyloid deposits
characteristically stain positive with Congo red (Fig. 9E), and
display birefringence and red-green di rhos under polarized
light (Fig. 9F). Also, deposits exhibit metachromasia with
crystal violet and ﬂuorescence with the use of thioﬂavin T
staining.
FIGURE 9. Lattice corneal dystro-
phy, type 1 (classic lattice). Direct
(A) and retroillumination (B) of early
lattice corneal dystrophy (LCD) with
dots and fine lattice lines with
genetic confirmation of Arg124Cys
in TGFBI. C, Subepithelial ground-
glass haze of the central and inferior
cornea, and diffuse lattice lines in
advanced LCD with genetic confir-
mation of Arg124Cys in TGFBI. D,
Dots and paracentral lattice lines in
retroillumination with genetic con-
firmation of Arg124Cys in TGFBI. E,
Light microscopy: Congo red (E)
prominently stains a continuous
layer of amyloid (asterisk) that un-
derlies and partially destroys the
Bowman layer and intrastromal
amyloid deposits corresponding to
lattice lines (arrowheads). F, This
same section viewed with polarized
light confirms deposits are birefrin-
gent and red-green dichroic, thus
amyloid. Arg124Cys TGFBI muta-
tion, bars = 200 mm. G, In vivo
confocal microscopy image shows
filaments corresponding to lattice
lines within the stroma (400 · 400
mm). Figure 9D from Figure 10A, in
Weiss JS, Møller HU, Lisch W, et al.
The IC3D classification of the corneal
dystrophies. Cornea. 2008;27(suppl
2):S1–S42.
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Transmission Electron Microscopy
Extracellular masses of ﬁne, electron-dense randomly
aligned ﬁbrils of uniform 8 to 10 nm diameter are character-
istic of amyloid protein. There are fewer keratocytes in the
areas of amyloid deposition: some are degenerated with
cytoplasmic vacuolization, whereas others appear metaboli-
cally active. Descemet membrane and the endothelium are
normal.
Confocal Microscopy
Linear and branching structures (Fig. 9G) in stroma
with changing reﬂectivity and poorly demarcated margins.
Such lines must be differentiated from other similar images
(ie, fungi).
Category
1.
Note: The LCD variants (Figs. 10A, B) are caused by more
than 2 dozen distinct heterozygous amyloidogenic mutations,
nearly all of which are located in the fourth FAS1 domain of
TGFBI. LCD variants (previously designated type IIIA, I/IIIA,
IV, and polymorphic amyloidosis) have a delayed onset
compared with classic LCD. The lattice lines may be larger,
with a limbus to limbus ropy appearance (type IIIA), thinner
(type I/IIIA), smaller (type IV) or even absent (polymorphic
amyloidosis), although one has to keep in mind that the lattice
pattern is very much dependent on age and mutation. Some
patients do not have clinically evident lattice lines. Corneal
epithelial erosions are a typical presenting sign of LCD, types
IIIA and I/IIIA, but are virtually absent in others (type IV and
polymorphic corneal amyloidosis). The frequency of recurrent
erosions is more common in subtypes that progress from
anterior to posterior (types IIIA and I/IIIA) compared with
those progress from posterior to anterior (type IV). Although
classic LCD has been found in numerous countries, LCD
variants are mostly geographically restricted. For example,
LCD type IIIA and LCD type IV were reported predominantly
in Japan and Italy, and the 2 LCD type IV variants were
reported to be derived from solitary founder mutations in Japan
and Italy.
Historically, multiple subtypes of lattice were created
on the basis of phenotypic and genotypic variations. The
so-called lattice corneal dystrophy type 2 (LCD2) is a mis-
nomer, in fact comprising systemic amyloidosis plus corneal
lattice lines and should be termed familial amyloidosis,
Finnish type, or gelsolin type. Eponymously, it is known as
Meretoja syndrome (Figs. 11A, B).
BIBLIOGRAPHY
 Biber H. Ueber einige seltene Hornhautkrankungen: die
oberﬂaechliche gittrige Keratitis [Inaugural dissertation].
Zurich;1890.
 Chiou AG, Beuermann RW, Kaufman SC, et al. Confocal
microscopy in lattice corneal dystrophy. Graefes Arch Clin
Exp Ophthalmol. 1999;237:697–701.
FIGURE 10. Lattice dystrophy var-
iants. A, Type IIIA with central
thicker ropy-appearing lattice lines
extending to the limbus. B, Type IV
with minimal findings of central
fleck-like opacities in deeper cornea
and few small lattice lines. Epithelial
erosions are typically absent because
there is posterior-to-anterior corneal
progression.
FIGURE 11. Familial amyloidosis
(Meretoja syndrome). A, Lax, mask-
like facies consequent to cranial
nerve VII palsy. B, Lattice lines are
less numerous than in classic and
variant LCD, start peripherally, and
spread centrally (Images provided
for differential diagnostic purposes).
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Granular Corneal Dystrophy, type 1
(Classic) (GCD1)
MIM #121900.
Former Alternative Names and Eponyms
Corneal dystrophy Groenouw type I.
Inheritance
Autosomal dominant.
Genetic Locus
5q31.
Gene
Transforming growth factor beta–induced—TGFBI.
Onset
Childhood, as early as 2 years of age.
Signs
In children, a vortex pattern (Fig. 12A) of brownish
granules develops superﬁcial to the Bowman layer. As the
patient ages, well-deﬁned granules appear white on direct
illumination with clear intervening stroma (Fig. 12B). The size
and number of granules increase resulting in snowﬂake
appearance (Fig. 12C and D). On retroillumination, these
granules are composed of extremely small, translucent dots with
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the appearance of vacuoles, glassy splinters, or crushed bread
crumbs. Opacities do not extend to the limbus. In later life,
granules extend into the deeper stroma approaching Descemet
membrane. Homozygotes have more severe manifestations.
Symptoms
Glare and photophobia are early symptoms. Visual
acuity decreases as opaciﬁcation progresses with age. Recur-
rent erosions are seen frequently. Homozygote cases have
more severe symptoms.
Course
With progression, opacities become more conﬂuent in
the superﬁcial cornea and reduce visual acuity. Serial
observation over time demonstrates in both GCD1 and
GCD2 that granule drop out after epithelial erosions may
actually result in stromal clearing.
Light Microscopy
Multiple stromal deposits may extend from deep
epithelium to Descemet membrane. Hyaline opacities stain
with Masson trichrome (Fig. 12E).
Transmission Electron Microscopy
Dense rod-shaped bodies are similar in appearance to
those in Reis–Bücklers corneal dystrophy.
Immunohistochemistry
Abnormal deposits react with antibodies to transform-
ing growth factor beta–induced protein (keratoepithelin).
Confocal Microscopy
Abnormal hyperreﬂective opacities in snowﬂake and
trapezoidal shapes.
Category
1.
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FIGURE 12. GCD, type 1 (GCD1).
A, In a child, early subepithelial ver-
ticillate-like opacities are evident by
retro and direct illumination. B, With
broad slit illumination, stromal de-
posits are both discrete and confluent,
and are axially distributed in anterior
stroma. C and D, In an adult, more
prominent diffuse granular opacities
in the form of “snowfall” are apparent
with direct (C) and retroillumination
(D). E, Light microscopy—Masson
trichrome highlights deposits of kera-
tohyalin at various stromal layers
and partial destruction of the Bow-
man layer (between arrowheads).
Arg555Trp TGFBImutation, bar = 240
mm. Figures 12B and C from Figures
12A and B in Weiss JS, Møller HU,
Lisch W, et al. The IC3D classification
of the corneal dystrophies. Cornea.
2008;27(suppl 2):S1–S42.
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Granular Corneal Dystrophy, type 2 (GCD2)
MIM #607541.
Former Alternative Names and Eponyms
Avellino dystrophy
Combined granular-lattice dystrophy
For nearly a century, this entity was considered a mild
GCD variant (Groenouw type I). Bücklers, as early as 1938,
described and depicted a large family with this phenotype.
Fifty years later, Weidle published reporting the same
patients and subdivided granular dystrophy according to
subtle clinical differences. In 1988, Folberg et al. described
the histopathology of both amyloid and hyaline deposits in
such patients. In 1992, the clinical ﬁndings of these patients
were published and termed Avellino corneal dystrophy. The
term Avellino (the district of Italy where the initial published
pedigree originated) came into popular and published usage
but is now considered obsolete because of the dystrophy’s
global occurrence. Others have used the term combined
granular-lattice dystrophy although the amyloid component
is typically only apparent by histopathology and does not
resemble lattice lines.
Inheritance
Autosomal dominant.
Genetic Locus
5q31.
Gene
Transforming growth factor beta–induced—TGFBI.
Onset
Homozygous patients have earlier onset with dystrophy
diagnosed, as early as 3 years of age, compared with
heterozygotes, who may be diagnosed as early as the age
of 8. Most GCD2 is diagnosed during teens or during early
adulthood.
Signs
In heterozygote, initial signs are subtle superﬁcial
stromal tiny whitish dots (Fig. 13A), which typically
develop small spokes or thorns. Some may be arranged
linearly like a string of pearls. Later, all eyes show
superﬁcial whitish round patches that have moth-eaten
centers so that they may even appear to be discoid or ring-
shaped. Most patients also develop spiky anterior to
midstromal deposits that are star, icicle, or spider-shaped
(Fig. 13B) and partially translucent in retroillumination (Fig.
13Bb). Patients may also have entirely translucent short
dash-like linear or dot-like deposits in the posterior stroma
deep to the branching stromal opacities.
The short lines or dashes sometimes observed in GCD2
can be distinguished from lattice lines observed in classic
LCD and most of its variants:
1. Dashes in GCD2 appear whiter, and lattice lines in
LCD are more refractile.
2. Dashes in GCD2 rarely cross each other, while lattice
lines in LCD characteristically intersect to result in the
pathognomonic lattice conﬁguration.
Consequent to epithelial erosions, spontaneous drop
out of superﬁcial granules results in clearing of the central
zone of opacity, which also becomes thickened with
recurrences. Ultimately, more superﬁcial translucent ﬂat-
tened breadcrumb opacities coalesce in the sub-Bowman
anterior stroma (Fig. 13C).
Phenotypic expressivity varies considerably with pa-
tients manifesting only a few white dots, and others showing
deposits throughout the stroma. Patients with GCD2 have
fewer stromal opacities than those with GCD1. Homozygote
patients initially demonstrate numerous small dots in the
superﬁcial cornea in early childhood. By adulthood, there are
larger, very dense irregularly shaped opacities in the super-
ﬁcial stroma that become deeper with time (Fig. 13D).
Symptoms
Vision decreases with age as the central visual axis
becomes affected. Pain accompanies epithelial erosions.
Course
Slowly progressive.
Homozygotes demonstrate more rapid progression.
Light Microscopy
Corneal opacities extend from the basal epithelium to the
deep stroma. There is deposition of both hyalin and amyloid and
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individual opacities stain with Masson trichrome and/or Congo
red (Fig. 13E). Homozygotes demonstrate more severe ﬁndings.
Transmission Electron Microscopy
Anterior stromal rod-shaped very electron-dense deposits
are similar to those noted in GCD1. On higher magniﬁcation,
the rod-shaped deposit is composed of extracellular masses of
ﬁne, electron-dense, highly aligned ﬁbrils. Enlarged kerato-
cytes of heterozygous corneal tissue demonstrate intracellular
organelles while details of the intracellular organelles are
barely discernible in normal cell cytoplasm. In heterozygous
tissue, keratocytes contain many dilated or degenerative
mitochondria and vesicles containing amorphous material.
An extremely common ultrastructural ﬁnding is the
presence of randomly aligned ﬁbrils of amyloid (see LCD
template).
Homozygotes demonstrate more severe ﬁndings.
Confocal Microscopy
Reﬂective breadcrumb-like round deposits with well-
delineated borders or highly reﬂective irregular trapezoidal
deposits are present in the anterior stroma (similar to GCD1).
FIGURE 13. GCD, type 2 (GCD2). A, A 13-year-old with few white dots and genetic confirmation of GCD2. B, Direct and (Bb)
retroillumination demonstrate branching, star-shaped, spiny, and ring-like deposits. C, Genetically confirmed GCD2 with
superficial translucent flattened breadcrumb opacity beneath the Bowman layer. Denser icicles and disc-like and ring-like
opacities. D, Genetically confirmed homozygote with denser and confluent opacities. E, Light microscopy—Masson trichrome
stains sub-Bowman and anterior stromal keratohyalin deposits red (arrowheads). Note that the deeper stromal layers do not have
keratohyalin granules (asterisk). In the deep stroma, small amyloid deposits stain with Congo red (inset), Arg124His TGFBI
mutation (bar = 300 and 200 mm inset). F, In vivo confocal microscopy shows abnormal hyperreflective stromal deposits with
a snowflake or trapezoidal shape within the corneal stroma (400 · 400 mm). Figures 13B from Figures 13B in Weiss JS, Møller HU,
Lisch W, et al. The IC3D classification of the corneal dystrophies. Cornea. 2008;27(suppl 2):S1–S4.
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Linear and branching deposits with changing reﬂectivity
(Fig. 13F) are observed (similar to those in LCD).
Category
1.
Note: Injury to the central cornea results in exacerbation of this
corneal dystrophy with accelerated opaciﬁcation. Hence, laser
in situ keratomileusis, photorefractive keratectomy, and laser
assisted in situ epithelial keratomileusis are strongly contra-
indicated in this dystrophy. Usually, GCD2 exacerbated more
after laser in situ keratomileusis than after laser assisted in situ
epithelial keratomileusis or photorefractive keratectomy.
In heterozygous GCD2 patients, superﬁcial photother-
apeutic keratectomy (PTK) may be judiciously used to reduce
visually signiﬁcant anterior stromal haze, recognizing that
repeated PTK treatments and possibly keratoplasty may be
eventually required. In homozygous GCD2, PTK results in
more rapid recurrence than in heterozygous GCD2. However,
when intervention is indicated, repeated PTK can be used in an
effort to postpone more deﬁnitive intervention by keratoplasty.
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STROMAL DYSTROPHIES
Macular Corneal Dystrophy (MCD)
MIM #217800.
Former Alternative Names and Eponyms
Groenouw corneal dystrophy type II.
Fehr speckled dystrophy.
Inheritance
Autosomal recessive.
Genetic Locus
16q22.
Gene
Carbohydrate sulfotransferase 6 gene—CHST6.
Onset
Childhood.
Signs
Initially, central, superﬁcial, irregular whitish ﬂeck-like
opacities develop, which give the condition its name (Fig. 14A);
and unlike GCD, these ﬂecks involve the limbus and the deep
stroma down to Descemet membrane (Fig. 14B). Simulta-
neously, a progressive diffuse haze develops, which involves
the entire corneal stroma (Fig. 14C). The epithelium remains
smooth, but occasionally develops corneal erosions.
The cornea is much thinner than normal. As the
disorder progresses, Descemet membrane becomes grayer
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and develops guttate excrescences although endothelial
decompensation rarely occurs.
Symptoms
Severe visual impairment occurs between 10 and 30
years of age. Corneal sensitivity is reduced. Photophobia and
painful recurrent erosions can rarely occur.
Course
Slowly progressive.
Light Microscopy
Breaks in the Bowman layer. Glycosaminoglycans
(GAGs) diffusely accumulate intracellularly and extracellu-
larly throughout the corneal stroma. Unique to stromal
dystrophies, Descemet membrane and endothelium are pri-
marily involved, as evidenced by Descemet thickening and
guttata plus endothelial staining with Hale colloidal iron or
Alcian blue (Fig. 14D).
Transmission Electron Microscopy
Keratocytes and endothelial cells stain positively for
GAGs and contain vacuoles and lamellar bodies. The
extracellular matrix contains focal and diffuse ﬁbrillogranular
GAGs.
Optical Coherence Microscopy
Time-domain and spectral domain OCT show hyper-
reﬂectivity throughout the corneal stroma corresponding to
diffuse corneal clouding together with diffuse hyperreﬂective
opacities especially in the Bowman layer. Spectral domain
OCT is able to visualize early changes in the Bowman layer,
while time-domain OCT reveals hyperreﬂective accumula-
tions in the anterior corneal stroma and peripheral posterior
cornea stroma.
Confocal Microscopy
Blurred limited accumulations of highly reﬂective
deposits are seen in the basal epithelium and anterior and
FIGURE 14. MCD. A, Early stage
with few central macular opacities. B,
Spreading of the deposits to the
limbus and to the deep stroma down
to Descemet membrane. C, More
diffuse opacities and haze involving
the entire stroma in an individual
with type 2 MCD associated with the
heterozygous c.1519T.C(p(Leu276-
Pro)) mutation in CHST6. D, Light
microscopy—intracellular and extra-
cellular accumulation of GAGs at all
levels of stroma and corneal endo-
thelium. Subepithelial fibrous tissue
also contains GAGs. Colloidal
iron, ·20. E, In vivo confocal micros-
copy image (400 · 400 mm) showing
hyperreflective abnormal areas within
the stroma. Some dark striae could
be observed within the hyper-
reflective material. Figure 14A from
Figure 14A in Weiss JS, Møller HU,
Lisch W, et al. The IC3D classification
of the corneal dystrophies. Cornea.
2008;27(suppl 2):S1–S42.
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mid stroma (Fig. 14E). Some of these may have dark striae-
like images. Normal keratocytes may not be seen.
Additional Findings
Although clinically indistinguishable, 3 variants of
MCD are distinguished on the basis of immunoreactivity of
speciﬁc sulfated epitopes of antigenic keratan sulfates
(AgKS) in the cornea and the serum.
• MCD type I: No AgKS reactivity in the cornea or in the serum.
• MCD type IA: Keratocytes manifest AgKS reactivity, but
the extracellular material does not. Serum lacks AgKS.
• MCD type II: All the abnormal deposits react positively with
AgKS, and the serum has normal or lower levels of AgKS.
Note: Electron microscopic corneal ﬁndings in sys-
temic mucopolysaccharidoses are similar to ﬁndings that are
seen in macular dystrophy. However, on clinical examina-
tion and light microscopy, cornea ﬁndings demonstrate more
diffuse and earlier opaciﬁcation without ﬂecks in mucopo-
lysaccharidoses that show corneal involvement (especially
Hurler, Hurler-Scheie, and Maroteaux–Lamy types). The
decisive phenotypical difference between MCD and the
mucopolysaccharidoses are the ﬂecks, which appear in
MCD.
Category
1.
Note: A single case of uniparental (maternal) isodisomy has
been reported that represents the ﬁrst evaluation in association
with a corneal dystrophy. Because MCD is recessively
inherited, 2 alleles need to carry a pathogenic mutation. In
this case, the father has 2 normal CHST6 genes, and the
mother has 1 normal and 1 mutated CHST6 gene. Because the
child has 2 identical CHST6 gene mutations (homozygous),
and nonpaternity was excluded, the only explanation is
a duplication of the chromosome or locus carrying the
mutated CHST6 from the mother.
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Schnyder Corneal Dystrophy (SCD)
MIM #21800.
Former Alternative Names and Eponyms
Schnyder crystalline corneal dystrophy (SCCD)
Schnyder crystalline dystrophy sine crystals.
Hereditary crystalline stromal dystrophy of Schnyder.
Crystalline stromal dystrophy.
Central stromal crystalline corneal dystrophy.
Corneal crystalline dystrophy of Schnyder.
Schnyder corneal crystalline dystrophy.
Inheritance
Autosomal dominant.
Genetic Locus
1p36.
Gene
UbiA prenyltransferase domain containing 1—UBIAD1.
Onset
Maybe as early as childhood, but diagnosis usually
made by the second or third decade. Diagnosis may be further
delayed in patients who have the acrystalline form of the
disease.
Signs
Corneal changes are predictable on the basis of age.
Patients 23 years or younger have ring- or disc-like
central corneal opacity and/or central crowded comma-
shaped subepithelial crystals (Figs. 15A, B). Between 23
and 38 years of age, arcus lipoides is also noted (Fig. 15 C).
After the age of 38, midperipheral panstromal haze also
develops, causing the entire cornea to appear hazy (Figs.
15D–F). Despite the former (now obsolete) name of SCCD,
only 50% of patients demonstrate corneal crystals. Crystals
may be unilateral, may rarely regress, and can occur late in
the disease.
Symptoms
Visual acuity decreases, and complaints of glare
increase with age. Although scotopic vision may be
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remarkably good (considering the slit-lamp appearance),
photopic vision may be disproportionately decreased. Corneal
sensation decreases with age. Both affected and unaffected
members of the pedigrees may have hyperlipoproteinemia
(type IIa, III, or IV).
Course
Although slowly progressive, the majority of patients
older than 50 years have severe reduction of photopic vision.
Light Microscopy
Abnormal deposition of intracellular and extracellular
esteriﬁed and unesteriﬁed phospholipids and cholesterol in
basal epithelial cells, the Bowman layer, and stroma. As
organic solvents and resins can dissolve lipids, staining for
lipids [such as Oil Red O (Fig. 15G) or Sudan black] are
facilitated by submitting fresh tissue for pathology, ensuring
appropriate ﬁxation for special stains. In addition, there are
FIGURE 15. SCD. A, Central stromal opacity in early SCD without crystals in a patient with mutation in UBIAD1. B, Early sub-
epithelial central crystalline deposit in a patient with mutation in UBIAD1. C, Central corneal opacity with arcus lipoides. D, Central
corneal opacity, subepithelial crystalline ring, mid peripheral haze, and arcus lipoides. E, Noncrystalline central diffuse opacity
pattern with clearer area centrally, mid peripheral haze and prominent arcus lipoides in a 39-year-old SCD patient with UBIAD1
mutation. F, Noncrystalline disc-like central opacity, mid peripheral haze and prominent arcus lipoides in a 72-year-old patient
with SCD with UBIAD1 mutation. G, Light microscopy—Oil Red O stains innumerable tiny lipid droplets within the corneal stroma
in a frozen section that has not undergone processing for paraffin embedding, which would dissolve the lipids and make the
staining negative, bar = 100 mm. H, Electron microscopy: empty crystalline space within a basal cell representing cholesterol
deposit dissolved during dehydration stage of embedding process ·10,000 (SCD with crystals). I, In vivo confocal microscopy
(400 · 400 mm) shows abnormal hyperreflective homogeneous spindle-shaped deposits within the anterior stroma (SCD with
crystals). Figure 15B and Figure 15C from Figure 15B and 15A in Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the
corneal dystrophies. Cornea. 2008;27(suppl 2):S1–S42.
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single published reports of SCD corneas with positive Congo
red staining, suggesting secondary amyloid deposition and
another with the addition of Alcian blue staining suggesting
secondary deposition of GAGs.
Transmission Electron Microscopy
Abnormal accumulation of intracellular and extracellu-
lar esteriﬁed and unesteriﬁed phospholipids and cholesterol
are deposited in the epithelium (Fig. 15H) in the Bowman
layer and throughout the stroma. Endothelial lipid has rarely
been reported.
Confocal Microscopy
Intracellular and extracellular highly reﬂective deposits
may lead to eventual disruption of the basal epithelial/
subepithelial nerve plexus (Fig. 15I).
Category
1.
Note: Although SCCD has been the more commonly used
name for this entity, this has caused diagnostic confusion as
only 50% of patients exhibit corneal crystals. Consequently,
SCD should be the preferred name. If the ophthalmologist
does not suspect SCD when performing keratoplasty, the
opportunity to perform lipid stains may be lost if the corneal
specimen is not preserved correctly (as speciﬁed above).
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Congenital Stromal Corneal Dystrophy (CSCD)
MIM #610048.
Former Alternative Names and Eponyms
Congenital hereditary stromal dystrophy.
Inheritance
Autosomal dominant.
Genetic Locus
12q21.33.
Gene
Decorin, DCN.
Onset
Congenital.
Signs
Diffuse, bilateral corneal clouding with ﬂake-like whitish
stromal opacities throughout the stroma (Fig. 16A). The changes
are equally pronounced in all areas of the cornea. The cornea
surface is normal and without ﬂuorescein staining or vascular-
ization. Pachymetry demonstrates increased stromal thickness.
Symptoms
Moderate to severe visual loss. Photophobia occurs in
a minority of patients.
Course
Nonprogressive or slowly progressive.
Light Microscopy
The stromal lamellae are irregularly separated and may
contain amorphous material (Fig. 16B).
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Transmission Electron Microscopy
Amorphous areas consisting of thin ﬁlaments randomly
arranged in an electron-lucent ground substance separate
lamellae of normal appearance (Fig. 16C). The changes can
be seen at all levels of the stroma. The abnormal layers are
broader in the posterior stroma. The keratocytes and endo-
thelium are normal, although absence of the anterior banded
zone of Descemet membrane has been reported. Accumula-
tion of decorin is found in the amorphous areas as determined
by immunoelectron microscopy.
Optical Coherence Tomography
Increased corneal thickness. Diffuse higher reﬂectivity
in the stroma.
Confocal Microscopy
Epithelial cells appear normal. Increased reﬂectivity
from the anterior stroma prevents further studies.
Category
1.
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Fleck Corneal Dystrophy (FCD)
MIM #121850.
Former Alternative Names and Eponyms
François-Neetens speckled (mouchetée) corneal
dystrophy.
Inheritance
Autosomal dominant.
Gene Locus
2q34.
Gene
Phosphoinositide kinase, FYVE ﬁnger containing—
PIKFYVE.
Note: Previously known as phosphatidylinositol-3-
phosphate/phosphatidylinositol 5-kinase type III—PIP5K3.
FIGURE 16. Congenital stromal corneal dystrophy. A, Diffuse clouding with flake-like opacities throughout the stroma in a 4-year-
old patient with a DCN frameshift mutation (c.967delT). B, Light microscopy: the cornea is markedly thickened with stromal
lamellae that are separated from each other in a regular manner with some areas of deposition, bar = 200 mm. C, Electron
microscopy—apparently normal collagen lamellae are separated by areas of amorphous substance with small filaments (arrows)
characteristic for the condition (original magnification ·20).
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Onset
Congenital or ﬁrst years of life.
Signs
Subtle but distinctive, small, translucent, discoid opac-
ities or discrete, ﬂat, gray–white, dandruff-like, and some-
times ring-shaped opacities scattered sparsely throughout any
level of the otherwise clear stroma (Figs. 17A, B). Flecks may
extend to the limbus and are best detected with slit beam or
retroillumination. The epithelium, Bowman layer, Descemet
membrane, and endothelium are not involved. Asymmetric or
unilateral corneal involvement is possible.
Symptoms
Asymptomatic, occasionally slight photophobia or
decreased corneal sensitivity.
Course
Nonprogressive.
Light Microscopy
Swollen, vacuolated keratocytes, which contain GAGs
(staining with Alcian blue and colloidal iron) and complex
lipids (demonstrated by Sudan black and Oil Red O).
Transmission Electron Microscopy
Some keratocytes show membrane-based inclusions
with delicate granular material.
Optical Coherence Tomography
Flecks correspond to slightly brighter small areas.
Confocal Microscopy
Accumulation of hyperreﬂective 2- to 18-mm dot-like
material in the normal-sized and enlarged stromal keratocyte
nuclei. Inclusions in basal nerves and doughnut- or kidney-
shaped 70- · 110-mm deposits have variably been reported.
Category
1.
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(mouchetée) dystrophy of the cornea. Ann Ophthalmol.
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Posterior Amorphous Corneal
Dystrophy (PACD)
MIM #612868.
Former Alternative Names and Eponyms
Posterior amorphous stromal dystrophy.
FIGURE 17. Fleck corneal dystrophy.
Dandruff-like opacities seen in 2 dif-
ferent patients throughout the
stroma using: (A) broad oblique illu-
mination, and (B) at varying depths
in the slit-lamp photograph. Figures
17A and B from Figures 17A and B in
Weiss JS, Møller HU, Lisch W, et al.
The IC3D classification of the corneal
dystrophies. Cornea. 2008;27(suppl
2):S1–S42.
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Inheritance
Autosomal dominant.
Genetic Locus
12q21.33.
Gene
Deletion of keratocan (KERA), lumican (LUM), decorin
(DCN), and epiphycan (EPYC).
Onset
Often occurs in the ﬁrst decade of life and has been
noted as early as 16 weeks, suggesting congenital origin.
Signs
PACD presents as diffuse gray-white sheet-like opac-
ities that can involve any layer of the stroma but are most
prominent posteriorly (Fig. 18A). The lesions can be
centroperipheral, extending to the limbus, or peripheral, the
latter with less pronounced ﬁndings and symptoms. Trans-
parent stromal breaks are often present. Decreased corneal
thickness (as thin as 380 mm) (Fig. 18B) and corneal
ﬂattening to less than 41 diopters with associated hyperopia
are characteristic, particularly in the centroperipheral form.
Descemet membrane and endothelium may be indented by
the opacities, and focal endothelial abnormalities have been
observed. Prominent Schwalbe line, ﬁne iris processes,
pupillary remnants, iridocorneal adhesions, corectopia, pseu-
dopolycoria, and anterior stromal tags have been reported,
particularly in patients with the centroperipheral pattern, but
there is no association with glaucoma.
Symptoms
Visual acuity is mildly affected, usually better than 20/40.
Course
None or slowly progressive in the majority of cases.
Light Microscopy
Irregularity of the posterior stromal lamellae with
colloidal iron staining, anterior to a thin Descemet membrane,
and focal attenuation of endothelial cells (Fig. 18C).
Transmission Electron Microscopy
There are abnormally oriented collagen ﬁbers and
abnormal keratocytes with disorganization of the posterior
stromal lamellae. A ﬁbrillar layer resembling stromal collagen
ﬁbers interrupts Descemet membrane. These ﬁndings are not
pathognomonic of this dystrophy and may be found in other
abnormalities. In 1 patient with more pronounced changes,
additional subepithelial deposits and a thick collagenous layer
posterior to Descemet membrane were present.
Confocal Microscopy
Microfolds and a hyperreﬂective layer in the posterior
stroma are present.
Category
1.
Note: The possible congenital onset, lack of progression and
association with iris abnormalities raises the possibility of
mesodermal dysgenesis rather than a true corneal dystrophy.
BIBLIOGRAPHY
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FIGURE 18. PACD. A, Central deep stromal/pre-Descemet opacity with some degree of peripheral extension interrupted by few
clear bands in the midperipheral cornea. B, Slit beam demonstrates decreased corneal thickness and posterior stromal lamellar
opacification. C, Light microscopy—extracellular colloidal iron stains positive material (arrowheads) in the posterior stroma, bar =
100 mm.
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One. 2014;9:e95037.
 Moshegov CN, Hoe WK, Wiffen SJ, et al. Posterior
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Central Cloudy Dystrophy of Franc¸ois
MlM #217600.
Former Alternative Names and Eponyms
None.
Inheritance
Unknown. Autosomal dominant inheritance is occa-
sionally reported. May be phenotypically indistinguishable
from posterior crocodile shagreen, which is a corneal
degeneration.
Gene/Genetic Locus
None.
Onset
First decade (youngest affected patient was 8 years old).
Signs
Fortuitous ﬁnding of cloudy central polygonal or
rounded stromal opacities that fade anteriorly and peripher-
ally and are surrounded by clear tissue (Fig. 19). The changes
are indistinguishable from Vogt posterior crocodile shagreen.
Symptoms
Mostly asymptomatic.
Course
Nonprogressive.
Light Microscopy
No description in familial cases. Faint undulating
appearance of the deep stroma and positive staining for
GAGs.
Transmission Electron Microscopy
No description in familial cases, therefore published
pathology could represent posterior crocodile shagreen.
Extracellular vacuoles, some containing ﬁbrillogranular mate-
rial and electron-dense deposits. Endothelial vacuoles with
ﬁbrillogranular material and a sawtoothed lamellar pattern
have also been reported.
Confocal Microscopy
No description in familial cases, therefore published
confocal microscopy could represent posterior crocodile sha-
green. In 2 unrelated patients, there were small highly refractile
granules and deposits in the anterior stroma. Multiple dark
striae in the extracellular matrix with increased intensity in the
deep posterior stroma adjacent to the endothelium.
Category
4.
Note: Many of the publications referenced did not provide
documentation that the corneal disease was familial. Conse-
quently, it is entirely possible that these cases reported as
CCDF might actually be posterior crocodile shagreen.
BIBLIOGRAPHY
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microscopy in patients with central cloudy dystrophy of
François. Arch Ophthalmol. 2004;122:1676–1679.
 Meyer JC, Quantock AJ, Thonar EJ, et al. Characterization
of a central corneal cloudiness sharing features of posterior
crocodile shagreen and central cloudy dystrophy of Fran-
çois. Cornea. 1996;15:347–354.
 Strachan IM. Cloudy central corneal dystrophy of François.
Five cases in the same family. Br J Ophthalmol.
1969;53:192–194.
 Zaidi A, McLeod SD. Laser in situ keratomileusis in
a patient with presumed central cloudy corneal dystrophy
of François. Am J Ophthalmol. 2005;139:376–377.
Pre-Descemet Corneal Dystrophy (PDCD)
MIM: none.
Former Alternative Names and Eponyms
None.
FIGURE 19. CCDF or posterior crocodile shagreen. No infor-
mation about family history available. Axially distributed,
polygonal gray-white stromal opacities separated by linear
areas of clear cornea. Figure 19 from Figure 19A in Weiss JS,
Møller HU, Lisch W, et al. The IC3D classification of the corneal
dystrophies. Cornea. 2008;27(suppl 2):S1–S42.
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Inheritance
Isolated pre-Descemet corneal dystrophy (PDCD) is
neither a well-deﬁned entity nor is it clearly a hereditary or
degenerative disorder (cornea farinata). Although there is no
deﬁnite pattern of inheritance, it has been described in
families over 2 to 4 generations. The subtype punctiform
and polychromatic PDCD has been reported to be AD in 1
pedigree and may represent a speciﬁc dystrophy. Similar deep
corneal opacities are frequently seen in X-linked ichthyosis
(MIM #308100).
Genetic Locus
Isolated PDCD—Unknown.
PDCD associated with X-linked ichthyosis—Xp22.31.
Gene
Isolated PDCD—Unknown.
PDCD associated with X-linked ichthyosis—Steroid
sulfatase (STS).
Onset
Usually after 30 years of age but has been found in
children as young as 3 years (punctiform and polychromatic
pre-Descemet dystrophy).
Signs
PDCD has several subgroups, many of which may
represent sporadic, age-related degenerative and secondary
changes. Focal, ﬁne, polymorphic gray opacities that may be
central, annular, or diffuse are located in the deep stroma
immediately anterior to Descemet membrane (Figs. 20A, B).
In the punctiform and polychromatic subtype, the changes are
more uniform and polychromatic, and the cornea is otherwise
normal. Similar opacities have been noted in association with
other ocular and systemic diseases, such as pseudoxanthoma
elasticum, X-linked ichthyosis, keratoconus, posterior poly-
morphous dystrophy, epithelial basement membrane dystro-
phy, and CCDF.
Symptoms
The vision is usually unaffected, and the patients are
asymptomatic.
Course
Punctiform and polychromatic PDCD is nonprogres-
sive. Other forms show progression.
Light Microscopy
Histopathologic studies are not consistent. Normal
cornea except for enlarged keratocytes in the posterior stroma
containing vacuoles and intracytoplasmic inclusions of lipid-
like material.
Transmission Electron Microscopy
Membrane-bound intracellular vacuoles containing
electron-dense material suggestive of secondary lysosomes
and inclusions of a lipofuscin-like lipoprotein consistent with
a degenerative process. No extracellular deposits noted.
Confocal Microscopy
Hyperreﬂective dots located anterior to Descemet mem-
brane, and in 1 case reported to be present throughout the stroma.
Category
1. PDCD associated with X-linked ichthyosis.
4. Isolated PDCD
BIBLIOGRAPHY
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 Grayson M, Wilbrandt M. Pre-Descemet dystrophy. Am J
Ophthalmol. 1967;64:276–282.
 Hung C, Ayabe RI, Wang C, et al. Pre-Descemet corneal
dystrophy and X-linked ichthyosis associated with deletion
of Xp22.31 containing the STS gene. Cornea.
2013;32:1283–1287.
 Kempster, RC, Hirst, LW, de la Cruz Z, et al. Clinicopath-
ologic study of the cornea in X-linked ichthyosis. Arch
Ophthalmol. 1997;115:409–415.
 Lisch W, Weidle EG. Die posteriore kristalline Hornhaut-
dystrophie. Klin Monatsbl Augenheilkd. 1984;185:128–
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 Ye YF, Yao YF, Zhou P, et al. In vivo confocal microscopy
of pre-Descemet’s membrane corneal dystrophy. Clin
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FIGURE 20. PDCD. A, With broad-
beam illumination, punctate opaci-
ties anterior to Descemet membrane
are apparent. B, Slit beam illumina-
tion of the same eye demonstrating
punctate opacities anterior to De-
scemet membrane.
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ENDOTHELIAL DYSTROPHIES
Fuchs Endothelial Corneal Dystrophy (FECD)
MIM #136800 (FECD1), MIM #610158 (FECD2), MIM
#613267 (FECD3), MIM #613268 (FECD4), MIM #613269
(FECD5), MIM #613270 (FECD6), MIM #613271 (FECD7),
MIM #615523 (FECD8).
Former Alternative Names and Eponyms
Endoepithelial corneal dystrophy.
Inheritance
Cases without known inheritance are most common.
Some cases with AD inheritance reported. Genetic basis of
FECD is complex and heterogeneous, demonstrating variable
expressivity and incomplete penetrance.
Genetic Locus
Early-Onset FECD
1p34.3–p32 (FECD1).
Late-Onset FECD
Association has been reported to 13pter-q12.13 (FECD2),
18q21.2-q21.3 (FECD3), 20p13-p12 (FECD4), 5q33.1-q35.2
(FECD5), 10p11.2 (FECD6), 9p24.1-p22.1 (FECD7), and
15q25 (FECD8).
Gene
Early-onset FECD: collagen, type VIII, alpha-2, COL8A2.
Onset
Most cases begin in the fourth decade or later, but the
early variant starts in the ﬁrst decade. Both early and later onset
forms have female predominance at a ratio of 2.5:1 to 3:1.
Signs
Cornea guttata starts centrally and spreads peripherally
(stage 1) (Fig. 21A). Some patients demonstrate guttae but
never progress to later stages, whereas others advance to
endothelial decompensation and stromal edema (stage 2).
Corneal endothelium has a beaten metal-like appearance with
or without pigment dusting. Corneal guttae in late-onset
FECD are larger than those seen in early-onset FECD.
Descemet membrane is thickened. Stromal edema may
progress to involve the epithelium causing intraepithelial
and interepithelial edema (epithelial bullae); bullous keratop-
athy (stage 3) (Figs. 21B, C). Subepithelial ﬁbrosis, scarring,
and peripheral superﬁcial vascularization from chronic edema
occur in long-standing cases (stage 4).
Symptoms
Intermittent reduced vision from epithelial/stromal
edema. Visual acuity worse in the morning because of
increased stromal/epithelial edema after overnight eye clo-
sure. Pain, photophobia, and epiphora due to epithelial
erosions resulting from ruptured epithelial bullae. Progressive
visual loss. Guttae alone may not cause corneal edema, and
mild cornea edema may not result in decreased vision. More
severe disease associated with decreased vision often has
epithelial and stromal edema and ﬁbrosis.
FIGURE 21. FECD. Cornea guttata
in retroillumination (A) and slit-lamp
view (Ai). B and C, Epithelial edema
and bullae, and stromal edema due
to endothelial decompensation. D,
Light microscopy: cornea guttata in
the form of focal excrescences at the
level of the endothelium; thickening
of Descemet membrane (arrow-
head); stromal and intraepithelial
edema. PAS, bar = 200 mm. E, In vivo
confocal microscopy shows poly-
megethism and pleomorphism of
endothelial cells associated with
round hyporeflective structures
sometimes containing reflective
material and corresponding to gut-
tae (400 · 400 mm). Figures 21B and
C from Figures 21B and D in Weiss
JS, Møller HU, Lisch W, et al. The
IC3D classification of the corneal
dystrophies. Cornea. 2008;27(suppl
2):S1–S42.
Weiss et al Cornea  Volume 34, Number 2, February 2015
152 | www.corneajrnl.com Copyright  2014 Wolters Kluwer Health, Inc. All rights reserved.
Course
Progressive.
Light Microscopy
Diffuse thickening and lamination of Descemet mem-
brane. Sparse and atrophic endothelial cells, hyaline excres-
cences (guttae) on thickened Descemet membrane (Fig. 21D).
Guttae become buried or conﬂuent, or may be absent.
Degeneration, thinning, and reduction of endothelial cells.
Increasing waviness of the stromal collagen lamellae.
Transmission Electron Microscopy
Early-onset FECD
Thickened anterior banded layer of Descemet mem-
brane. Degeneration of endothelial cells. Stromal thickening
with severe disorganization and disruption of the lamellar
pattern.
Late-onset FECD
Multiple layers of basement membrane–like material on
the posterior nonbanded part of Descemet membrane.
Confocal Microscopy
Polymegethism, pleomorphism, decreased hexagonal-
ity, and reduced number of endothelial cells (Fig. 21E).
Category
1. early-onset FECD.
2. in patients with identiﬁed genetic loci.
3. in patients without known inheritance.
BIBLIOGRAPHY
 Aldave AJ, Han J, Frausto RF. Genetics of the corneal
endothelial dystrophies: an evidence based review. Clin
Genet. 2013;84:109–119.
 Baratz KH, Tosakulwong N, Ryu E, et al. E2-2 protein and
Fuchs’s corneal dystrophia. N Engl J Med. 2010;363:1016–
1024.
 Biswas S, Munier FL, Yardley J, et al. Missense mutations
in COL8A2, the gene encoding the alpha2 chain of type
VIII collagen, cause two forms of corneal endothelial
dystrophy. Hum Mol Genet. 2001;10:2415–2423.
 Bucher F, Adler W, Lehmann HC, et al. Corneal nerve
alterations in different stages of Fuchs’ endothelial corneal
dystrophy: an in vivo confocal microscopy study. Graefes
Arch Clin Exp Ophthalmol. 2014;252:1119–1126.
 Fuchs E. Dystrophea epithelialis corneae. Arch Ophthalmol.
1910;76:478–508.
 Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of
a novel COL8A2 mutation deﬁnes a distinct early-onset
subtype of Fuchs corneal dystrophy. Invest Ophthalmol Vis
Sci. 2005;46:1934–1939.
 Hogan MJ, Wood J, Fine M. Fuchs’endothelial dystrophy
of the cornea. Am J Ophthalmol. 1974;78:363–383.
 Krachmer JH, Purcell JJ Jr, Joung CW, et al. Corneal
endothelial dystrophy. A study of 64 families. Arch
Ophthalmol. 1978;96:2036–2039.
 Magovern M, Beauchamp GR, McTigue JW, et al. Inheri-
tance of Fuchs’ combined dystrophy. Ophthalmology.
1979;86:1897–1923.
 Mootha VV, Gong X, Ku HC, et al. Association and
familial segregation of CTG18.1 trinucleotide repeat
expansion of TCF4 gene in Fuchs’ endothelial corneal
dystrophy. Invest Ophthalmol Vis Sci. 2014;55:33–42.
 Riazuddin SA, Eghrari AO, Al-Saif A, et al. Linkage of
a mild late-onset phenotype of Fuchs corneal dystrophy to
a novel locus at 5q33.1-q35.2. Invest Ophthalmol Vis Sci.
2009;50:5667–5671.
 Riazuddin SA, Parker DS, McGlumphy EJ, et al. Mutations
in LOXHD1, a recessive-deafness locus, cause dominant
late-onset Fuchs corneal dystrophy. Am J Hum Genet.
2012;90:533–539.
 Riazuddin SA, Vasanth S, Katsanis N, et al. Mutations in
AGBL1 cause dominant late-onset Fuchs corneal dystro-
phy and alter protein-protein interaction with TCF4. Am J
Hum Genet. 2013;93:758–764.
 Riazuddin SA, Vithana EN, Seet LF, et al. Missense
mutations in the sodium borate cotransporter SLC4A11
cause late-onset Fuchs corneal dystrophy. Hum Mutat.
2010;31:1261–1268.
 Riazuddin SA, Zaghloul NA, Al-Saif A, et al. Missense
mutations in TCF8 cause late-onset Fuchs corneal dystro-
phy and interact with FCD4 on chromosome 9p. Am J Hum
Genet. 2010;86:45–53.
 Sundin OH, Broman KW, Chang HH, et al. A common locus
for late-onset Fuchs corneal dystrophy maps to 18q21.2-
q21.32. Invest Ophthalmol Vis Sci. 2006;47:3919–3926.
 Sundin OH, Jun AS, Broman KW, et al. Linkage of late-
onset Fuchs corneal dystrophy to a novel locus at 13pTel-
13q12.13. Invest Ophthalmol Vis Sci. 2006;47:140–145.
 Vithana EN, Morgan PE, Ramprasad V, et al. SLC4A11
mutations in Fuchs endothelial corneal dystrophy. Hum
Mol Genet. 2008;17:656–666.
 Wieben ED, Alaff RA, Tosakulwong N, et al. A common
trinucleotide repeat expansion within the transcription
factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystro-
phy. PLoS One. 2012;7:e49083.
 Zhang C, Bell WR, Sundin OH, et al. Immunohistochem-
istry and electron microscopy of early-onset Fuchs corneal
dystrophy in three cases with the same L450W COL8A2
mutation. Trans Am Ophthalmol Soc. 2006;104:85–97.
Posterior Polymorphous Corneal
Dystrophy (PPCD)
MIM #122000 (PPCD1), MIM #609140 (PPCD2),
MIM #609141 (PPCD3).
Former Alternative Names and Eponyms
Posterior polymorphous dystrophy.
Schlichting dystrophy.
Inheritance
Autosomal dominant.
Isolated unilateral cases, with similar phenotype but no
heredity.
Cornea  Volume 34, Number 2, February 2015 IC3D Classification of Corneal Dystrophies
Copyright  2014 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 153
Genetic Locus
PPCD 1: 20p11.2-q11.2.
PPCD 2: 1p34.3-p32.3.
PPCD 3: 10p11.22.
Gene
PPCD1: unknown.
PPCD2: collagen, type VIII, alpha-2 (COL8A2).
PPCD 3: zinc ﬁnger E box–binding homeobox 1 (ZEB1).
Onset
Early childhood.
Signs
Often asymmetric. Opacities of Descemet membrane
and endothelium with characteristic morphologic features:
geographic gray opacities; vesicular lesions, either single or
grouped, often surrounded by gray circular opacity; parallel
gray-white endothelial bands with white “ﬂaky” material
along the bands (railroad tracks), which may extend across
the entire cornea (Figs. 22A–C). Occasional cases may be
associated with diffuse opaciﬁcation of Descemet membrane
and multiple larger vesicular endothelial opacities. Both
keratoconic and nonkeratoconic corneal steepening have been
reported, with the majority of individuals with PPCD3
demonstrating corneal curvatures greater than 48.0 diopters
in both eyes. Corneal edema may develop, necessitating
corneal transplantation in approximately 20% to 25% of
affected individuals. Peripheral iridocorneal adhesions in
about 25% of cases and elevated intraocular pressure in about
15% of cases.
Symptoms
Endothelial alterations often asymptomatic. Visual
impairment may develop secondary to corneal edema.
Course
Rarely congenital corneal clouding. Endothelial
changes often unchanged over years. Possible slow pro-
gression of polymorphic vesicles and greater thickness of
Descemet membrane over years and decades occasionally
causing endothelial decompensation.
Light Microscopy
Descemet membrane with multiple layers of collagen
on its posterior surface manifesting focal fusiform or nodular
excrescences. Blebs, discontinuities, or reduplication of the
endothelial cell layer (Fig. 22D).
Transmission Electron Microscopy
The anterior banded portion of Descemet membrane is
normal, although the posterior nonbanded portion may be
FIGURE 22. PPCD. A, Endothelial plaque–like lesions. B, Irregular crater-like figures on Descemet membrane viewed with specular
reflection. C, Endothelial railroad track alteration. D, Light microscopy: PAS stain (i) and Masson trichrome (ii) show that the
endothelium is replaced with flat epithelial-like cells that grow focally as more than 1 layer of cells (i; asterisk) and forms blisters
(ii; arrowheads) and occasionally elevated strands. Posterior stroma may show pits or discontinuities in Descemet membrane
(i; arrowhead), bar = 100 mm. E, In vivo confocal microscopy showing vesicular lesions and band-like structures with irregular
edges within the endothelium associated with polymegethism of endothelial cells (400 · 400 mm). Figures 22A, B, and C from
Figures 22A, B, and C in Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. Cornea. 2008;27
(suppl 2):S1–S42.
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markedly abnormal, demonstrating alterations in thickness,
a multilaminar appearance and occasional guttae. Two types
of collagenous tissue posterior to Descemet membrane form
layers up to 25 nm thick. Affected endothelial cells display
ultrastructural characteristics of epithelial cells, such as
microvilli and desmosomes.
Immunohistochemistry
PPCD 1: positive with anti-CK7, CK8, CK18, and
CK19 antibodies.
Confocal Microscopy
Vesicular lesions: rounded dark areas with some cell
detail apparent in the middle giving a doughnut-like appear-
ance (Fig. 22E). Multilayered nests of cells. “Railroad-track”:
band-like dark area with irregular edges enclosing some
smaller lighter epithelial-like cells. Polymegethism of the
endothelium.
Category
1. PPCD 2 and PPCD 3
2. PPCD 1
Note: Clinical, histopathologic, and electron microscopic
descriptions of 2 of the 5 families reported with AD CHED
(Kanai A, Kaufman HE. Invest Ophthalmol. 1971; Kanai A,
Waltman S, Polack FM, et al. Invest Ophthalmol. 1971; and
Levenson JE, Chandler JW, Kaufman HE. Am J Ophthalmol.
1973) are consistent with PPCD, although neither linkage to the
PPCD1 locus nor ZEB1 screening has been performed in either
family. Another of the 5 families (Pearce et al. Br J
Ophthalmol. 1969; Kirkness, et al. Br J Ophthalmol. 1987;
and Toma, et al. HumMol Genet. 1995) may have PPCD based
on clinical, histopathologic, and electron microscopic analyses,
although a higher percentage of affected individuals in this
family demonstrate corneal edema, with an earlier onset and
more signiﬁcant edema compared with the majority of families
with PPCD. Because linkage analysis in this family demon-
strated linkage to the region of chromosome 20 that is common
to 4 families with PPCD, it is probable that the family
originally reported by Pearce et al also has PPCD1, with a more
severe phenotype than that of other PPCD1 pedigrees.
However, as it is possible that the corneal endothelial dystrophy
in this family and PPCD1 are allelic variants, or are associated
with mutations in 2 different genes in the common linked
interval for these endothelial dystrophies, we support the use of
the original name used by Pearce et al, congenital endothelial
corneal dystrophy, to describe the condition in this family.
Identiﬁcation of the genetic basis of PPCD1 will allow
deﬁnitive determination of whether PPCD1 and congenital
endothelial corneal dystrophy are in fact the same.
BIBLIOGRAPHY
 Aldave AJ, Ann LB, Frausto RF, et al. Classiﬁcation of
posterior polymorphous corneal dystrophy as a corneal
ectatic disorder following conﬁrmation of associated signif-
icant corneal steepening. JAMA Ophthalmol.
2013;131:1583–1590.
 Bakhtiari P, Frausto RF, Roldan AN, et al. Exclusion of
pathogenic promoter region variants and identiﬁcation of
novel nonsense mutations in the zinc ﬁnger E-box binding
homeobox 1 gene in posterior polymorphous corneal
dystrophy. Mol Vis. 2013;19:575–580.
 Cibis GW, Krachmer JA, Phelps CD, et al. The clinical
spectrum of posterior polymorphous dystrophy. Arch
Ophthalmol. 1977;95:1529–1537.
 Héon E, Mathers WD, Alward WL, et al. Linkage of
posterior polymorphous corneal dystrophy to 20q11. Hum
Mol Genet. 1995;4:485–488.
 Kanai A, Kaufman HE. Further electron microscopic study of
hereditary corneal edema. Invest Ophthalmol. 1971;10:545–554.
 Kanai A, Waltman S, Polack FM, et al. Electron micro-
scopic study of hereditary corneal edema. Invest Ophthal-
mol. 1971;10:89–99.
 Kirkness CM, McCartney A, Rice NS, et al. Congenital
hereditary corneal oedema of Maumenee: its clinical
features, management, and pathology. Br J Ophthalmol.
1987;71:130–144.
 Koeppe L. Klinische Beobachtungen mit der Nernstspalt-
lampe und dem Hornhautmikroskop. Albrecht von Graefes
Arch Klin Exp Ophthalmol. 1916;91:363–379.
 Krafchak CM, Pawar H, Moroi SE, et al. Mutations in
TCF8 cause posterior polymorphous corneal dystrophy and
ectopic expression of COL4A3 by corneal endothelial cells.
Am J Hum Genet. 2005;77:694–708.
 Levenson JE, Chandler JW, Kaufman HE. Affected
asymptomatic relatives in congenital hereditary endothelial
dystrophy. Am J Ophthalmol. 1973;76:967–971.
 Patel DV, Grupcheva CN, McGhee CNJ. In vivo micros-
copy of posterior polymorphous dystrophy. Cornea.
2005;24:550–554.
 Pearce WG, Tripathi RC, Morgan G. Congenital endothe-
lial corneal dystrophy. Clinical, pathological, and genetic
study. Br J Ophthalmol. 1969;53:577–591.
 Rodrigues MM, Waring GO, Laibson PR, et al. Endothelial
alterations in congenital corneal dystrophies. Am J Ophthal-
mol. 1975;80:678–689.
 Schlichting H. Blasen-und dellenförmige Endotheldystrophie
der Hornhaut. Klin Monatsbl Augenkeilkd. 1941;107:425–435.
 Shimizu S, Krafchak C, Fuse N, et al. A locus for posterior
polymorphous corneal dystrophy (PPCD3) maps to chro-
mosome 10. Am J Med Genet. 2004;130:372–377.
 Toma NM, Ebenezer ND, Inglehearn CF, et al. Linkage of
congenital hereditary endothelial dystrophy to chromosome
20. Hum Mol Genet. 1995;4:2395–2398.
 Yellore VS, Rayner SA, Emmert-Buck L, et al. No
pathogenic mutations identiﬁed in the COL8A2 gene or
four positional candidate genes in patients with posterior
polymorphous corneal dystrophy. Invest Ophthalmol Vis
Sci. 2005;46:1599–1603.
Congenital Hereditary Endothelial
Dystrophy (CHED)
MIM #217700.
Note: To date there is no convincing published
evidence to support the existence of AD CHED as a distinct
Cornea  Volume 34, Number 2, February 2015 IC3D Classification of Corneal Dystrophies
Copyright  2014 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 155
entity. Therefore, we have removed AD CHED, formerly
known as CHED1, from our classiﬁcation system, so that AR
CHED formerly known as CHED2 will be renamed CHED.
Former Alternative Names and Eponyms
Maumenee corneal dystrophy.
Inheritance
Autosomal recessive.
Genetic Locus
20p13.
Gene
Solute carrier family 4, sodium borate transporter,
member 11—(SLC4A11) gene mutations identiﬁed in 76%
of CHED pedigrees screened in 1 publication.
Onset
Congenital.
Signs
Bilateral. Often asymmetric. Corneal clouding ranging
from diffuse haze to ground-glass milky appearance with
occasional focal gray spots (Figs. 23A, B). Thickening of the
cornea (can be 2–3 times the normal thickness) (Fig. 23C).
Rarely secondary subepithelial band keratopathy. Rarely
elevated intraocular pressure. Endothelial cell count reduced
signiﬁcantly (about 10-fold as compared with age-matched
controls).
Symptoms
Corneal clouding with blurred vision often accompa-
nied by nystagmus. Minimal to no tearing or photophobia.
Course
Relatively stationary with little or no progression.
Light Microscopy
Diffuse epithelial and stromal edema (Fig. 23D),
defects in the Bowman layer, degenerated corneal endothe-
lium with multinucleated sparse and atrophic endothelial
cells, and a thickened laminated Descemet membrane (Fig.
23E) due to abnormal and accelerated secretion by the
endothelial cells.
Transmission Electron Microscopy
Multiple layers of basement membrane–like material on
the posterior part of Descemet membrane. Degeneration of
endothelial cells with many vacuoles. Stromal thickening
with severe disorganization and disruption of the lamellar
pattern.
Immunohistochemistry
Collagen types I, III and V within the posterior
collagenous layer of Descemet membrane from ﬁbroblast-
like change of the endothelial cells.
FIGURE 23. CHED. A and B, Right and left corneas of a 30-year-old woman with CHED. Screening of SLC4A11 demonstrated
a homozygous (Thr271Met) mutation. Photograph courtesy of Dr Majid Moshirfar. C, Slit-beam photograph demonstrating
diffuse stromal thickening in an individual with SLC4A11 mutations. D, Light microscopy: edema of basal epithelial cells with
subepithelial lacunae (open arrowhead) and breaks (arrowhead) in the Bowman layer, bar = 80 mm. E, Thickened Descemet
membrane with no visible endothelial cells, bar = 50 mm. Figure 23C from Figure 23B in Weiss JS, Møller HU, Lisch W, et al. The
IC3D classification of the corneal dystrophies. Cornea. 2008;27(suppl 2):S1–S42.
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Confocal Microscopy
Not reported.
Category
1.
3 for patients without SLC4A11 mutations.
Note: Mutations in SLC4A11 are also responsible for
Harboyan syndrome, a disorder involving congenital corneal
endothelial dystrophy and progressive postlingual sensori-
neural hearing loss.
BIBLIOGRAPHY
 Aldahmesh MA, Khan AO, Meyer BF, et al. Mutational
spectrum of SLC4A11 in autosomal recessive CHED in
Saudi Arabia. Invest Ophthalmol Vis Sci. 2009;50:4142–
4145.
 Aldave AJ, Han J, Frausto RF. Genetics of the corneal
endothelial dystrophies: an evidence based review. Clin
Genet. 2013;84:109–119.
 Aldave AJ, Yellore VS, Bourla N, et al. Autosomal
recessive CHED associated with novel compound hetero-
zygous mutations in SLC4A11. Cornea. 2007;26:896–900.
 Callaghan M, Hand CK, Kennedy SM, et al. Homozygos-
ity mapping and linkage analysis demonstrate that autoso-
mal recessive congenital hereditary endothelial dystrophy
(CHED) and autosomal dominant CHED are genetically
distinct. Br J Ophthalmol. 1999;83:115–119.
 Desir J, Abramowicz M. Congenital hereditary endothelial
dystrophy with progressive sensorineural deafness (Har-
boyan syndrome). Orphanet J Rare Dis. 2008;3:28. doi:
10.1186/1750-1172-3-28.
 Desir J, Moya G, Reish O, et al. Borate transporter
SLC4A11 mutations cause both Harboyan syndrome and
non-syndromic corneal endothelial dystrophy. J Med
Genet. 2007;44:322–326.
 Ehlers N, Modis L, Moller-Pedersen T. A morphological
and functional study of congenital hereditary endothelial
dystrophy. Acta Ophthalmol Scand. 1998;76:314–318.
 Jalimarada SS, Ogando DG, Vithana EN, et al. Ion transport
function of SLC4A11 in corneal endothelium. Invest
Ophthalmol Vis Sci. 2013;54:4330–4340.
 Jiao X, Sultana A, Garg P, et al. Autosomal recessive
corneal endothelial dystrophy (CHED2) is associated with
mutations in SLC4A11. J Med Genet. 2007;44:64–68.
 Kenyon KR, Antine B. The pathogenesis of congenital
hereditary endothelial dystrophy of the cornea. Am J
Ophthalmol. 1971;72:787–795.
 Kim JH, Ko JM, Tchah H. Fuchs endothelial corneal
dystrophy in a heterozygous carrier of congenital hereditary
endothelial dystrophy type 2 with a novel mutation in
SLC4A11. Ophthalmic Genet. 2014. [Epub ahead of print].
 Kirkness CM, McCartney A, Rice NS, et al. Congenital
hereditary corneal edema of Maumenee: its clinical
features, management, and pathology. Br J Ophthalmol.
1987;71:130–144.
FIGURE 24. X-linked endothelial
corneal dystrophy. A, Male infant with
congenital corneal haze. B, The
mother of the infant with moon crater-
like endothelial changes in retro-
illumination. C, Light microscopy:
scarce endothelial cells (arrowheads)
with atypical appearance, bar = 100
mm. D, Electron microscopy: degener-
ative endothelial cell adjacent to
denuded area (arrow) of Descemet
membrane (DN), ·10,000. N, nucleus.
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 Loganathan SK, Casey JR. Corneal dystrophy-causing
SLC4A11 mutants: suitability for folding-correction ther-
apy. Hum Mutat. 2014;35:1082–1091.
 Maumenee AE. Congenital hereditary corneal dystrophy.
Am J Ophthalmol. 1960;50:1114–1124.
 Mittal V, Mittal R. Challenges in pediatric endothelial
keratoplasty. Indian J Ophthalmol. 2014;62:251–254.
 Sekundo W, Marshall GE, Lee WR, et al. Immuno-electron
labeling of matrix components in congenital hereditary
endothelial dystrophy. Graefes Arch Clin Exp Ophthalmol.
1994;232:337–346.
 Shah SS, Al-Rajhi A, Brandt JD, et al. Mutation in the
SLC4A11 gene associated with autosomal recessive con-
genital hereditary endothelial dystrophy in a large Saudi
family. Ophthalmic Genet. 2008;29:41–45.
 Siddiqui S, Zenteno JC, Rice A, et al. Congenital hereditary
endothelial dystrophy caused by SLC4A11 mutations pro-
gresses to Harboyan syndrome. Cornea. 2014;33:247–251.
 Sultana A, Garg P, Ramamurthy B, et al. Mutational spectrum
of the SLC4A11 gene in autosomal recessive congenital
hereditary endothelial dystrophy. Mol Vis. 2007;13:1327–
1332.
 Vithana EN, Morgan P, Sundaresan P, et al. Mutations in
sodium-borate cotransporter SLC4A11 cause recessive
congenital hereditary endothelial dystrophy (CHED 2).
Nat Genet. 2006;38:755–757.
X-linked Endothelial Corneal
Dystrophy (XECD)
MIM: none.
Former Alternative Names and Eponyms
None.
Inheritance
X-chromosomal dominant.
Genetic Locus
Xq25.
Gene
Unknown.
Onset
Congenital.
Signs
Males
Congenital clouding ranging from diffuse haze to ground-glass,
milky appearance (Fig. 24A). Possible nystagmus.
Only moon crater-like endothelial changes.
Secondary subepithelial band keratopathy combined with
moon crater-like endothelial changes.
Females
Only moon crater-like endothelial changes (Fig. 24B).
Symptoms
Males
Often blurred vision.
Females
Asymptomatic.
Course
Males
Minimally progressive.
Females
Nonprogressive.
Light Microscopy
Moon crater-like endothelial changes and subepithelial
keratopathy. Irregular thinning of the epithelium and Bow-
man layer. Anterior stroma with irregularly arranged collagen
lamellae. Irregular thickening of Descemet membrane with
small excavations and pits. Loss of endothelial cells or
atypical appearance (Fig. 24C).
Transmission Electron Microscopy
Moon crater-like endothelial changes and subepithelial
band keratopathy. Subepithelial accumulations of an amor-
phous granular material. Irregular thinning of the Bowman
layer (up to 0.5 mm) with many interruptions and gaps.
Thickening of Descemet membrane (20–35 mm) consisting of
an abnormal anterior and posterior banded zone. Complete
absence of the posterior nonbanded zone. Discontinuous
endothelial layer with partly normal and partly degenerative
appearing cells (Fig. 24D). No evidence of desmosome-like
adherent junctions between the cells or tonoﬁlament bundles
within the cytoplasm.
Confocal Microscopy
Not reported.
Category
2.
BIBLIOGRAPHY
 Lisch W. Primaere bandfoermige Hornhautdegeneration
und ihre Assoziation mit anderen erblichen Hornhautver-
aenderungen. Klin Monatsbl Augenheilkd. 1976;169:717–
727.
 Schmid E, Lisch W, Philipp W, et al. A new, X-linked
endothelial corneal dystrophy. Am J Ophthalmol.
2006;141:478–487.
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